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A B S T R A C T
Background
The number of people living with dementia is increasing rapidly. Clinical dementia does not develop suddenly, but rather is preceded
by a period of cognitive decline beyond normal age-related change. People at this intermediate stage between normal cognitive function
and clinical dementia are often described as having mild cognitive impairment (MCI). Considerable research and clinical efforts have
been directed toward finding disease-modifying interventions that may prevent or delay progression from MCI to clinical dementia.
Objectives
To evaluate the effects of at least 12 weeks of computerised cognitive training (CCT) on maintaining or improving cognitive function
and preventing dementia in people with mild cognitive impairment.
Search methods
We searched to 31 May 2018 in ALOIS (www.medicine.ox.ac.uk/alois) and ran additional searches in MEDLINE, Embase, PsycINFO,
CINAHL, ClinicalTrials.gov, and the WHO portal/ICTRP ( www.apps.who.int/trialsearch) to identify published, unpublished, and
ongoing trials.
Selection criteria
We included randomised controlled trials (RCTs) and quasi-RCTs in which cognitive training via interactive computerised technology
was compared with an active or inactive control intervention. Experimental computerised cognitive training (CCT) interventions
had to adhere to the following criteria: minimum intervention duration of 12 weeks; any form of interactive computerised cognitive
training, including computer exercises, computer games, mobile devices, gaming console, and virtual reality. Participants were adults
with a diagnosis of mild cognitive impairment (MCI) or mild neurocognitive disorder (MND), or otherwise at high risk of cognitive
decline.
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Data collection and analysis
Two review authors independently extracted data and assessed risk of bias of the included RCTs. We expressed treatment effects as
mean differences (MDs) or standardised mean differences (SMDs) for continuous outcomes and as risk ratios (RRs) for dichotomous
outcomes. We used the GRADE approach to describe the overall quality of evidence for each outcome.
Main results
Eight RCTs with a total of 660 participants met review inclusion criteria. Duration of the included trials varied from 12 weeks to 18
months. Only one trial used an inactive control. Most studies were at unclear or high risk of bias in several domains. Overall, our
ability to draw conclusions was hampered by very low-quality evidence. Almost all results were very imprecise; there were also problems
related to risk of bias, inconsistency between trials, and indirectness of the evidence.
No trial provided data on incident dementia. For comparisons of CCT with both active and inactive controls, the quality of evidence
on our other primary outcome of global cognitive function immediately after the intervention period was very low. Therefore, we were
unable to draw any conclusions about this outcome.
Due to very low quality of evidence, we were also unable to determine whether there was any effect of CCT compared to active
control on our secondary outcomes of episodic memory, working memory, executive function, depression, functional performance,
and mortality. We found low-quality evidence suggesting that there is probably no effect on speed of processing (SMD 0.20, 95%
confidence interval (CI) -0.16 to 0.56; 2 studies; 119 participants), verbal fluency (SMD -0.16, 95% CI -0.76 to 0.44; 3 studies; 150
participants), or quality of life (mean difference (MD) 0.40, 95% CI -1.85 to 2.65; 1 study; 19 participants).
When CCT was compared with inactive control, we obtained data on five secondary outcomes, including episodic memory, executive
function, verbal fluency, depression, and functional performance. We found very low-quality evidence; therefore, we were unable to
draw any conclusions about these outcomes.
Authors’ conclusions
Currently available evidence does not allow us to determine whether or not computerised cognitive training will prevent clinical dementia
or improve or maintain cognitive function in those who already have evidence of cognitive impairment. Small numbers of trials, small
samples, risk of bias, inconsistency between trials, and highly imprecise results mean that it is not possible to derive any implications for
clinical practice, despite some observed large effect sizes from individual studies. Direct adverse events are unlikely to occur, although
the time and sometimes the money involved in computerised cognitive training programmes may represent significant burdens. Further
research is necessary and should concentrate on improving methodological rigour, selecting suitable outcomes measures, and assessing
generalisability and persistence of any effects. Trials with long-term follow-up are needed to determine the potential of this intervention
to reduce the risk of dementia.
P L A I N L A N G U A G E S U M M A R Y
Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Background
The terms ’cognition’ and ’cognitive function’ describe all of the mental activities related to thinking, learning, remembering, and
communicating. There are normal changes in cognition with age, There are also diseases that affect cognition, principally dementia,
in which cognition is impaired to the point of affecting a person’s ability to manage daily activities. More common than dementia is
a condition often described as mild cognitive impairment (MCI), in which mild impairment of cognition, more than expected from
age alone, can be detected on testing, but by which daily functioning is largely unaffected. For some people, MCI is a stage on the
way to developing dementia. There is a lot of interest in anything that might prevent further decline in cognition in people with MCI.
One thing that has been suggested as a means of doing this is computerised cognitive training (CCT). Cognitive training consists of a
set of standardised tasks intended to ’exercise the brain’ in various ways. These days, cognitive training exercises are often delivered via
computers or mobile technology, so that people can do them on their own at home. We wanted to know whether CCT is an effective
way for people with MCI to maintain their cognitive function and reduce their risk of going on to develop dementia.
What we did
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We searched the medical literature up to 15 March 2018 for trials in which a group of people with MCI had participated in CCT for
at least 12 weeks and had been compared with another group that had not received any CCT. This ’control’ group could have taken
part in an alternative activity instead, or group members could have received no intervention at all. For the comparison to be as fair as
possible, it should have been decided at random whether people were in the CCT or control group. We were primarily interested in
whether study participants developed dementia and in their overall cognitive function, but we also looked for evidence on particular
cognitive skills, daily activities, quality of life, mood, or mental well-being, and any harmful effects.
What we found
We found eight trials with 660 participants to include in the review. Seven of the trials (623 participants) compared CCT to an
alternative activity. None of the included trials examined development of dementia, so this review presents no evidence on whether
taking part in computerised cognitive training will help to prevent dementia. Our main finding in relation to all of the other outcomes
in which we were interested was that the overall quality of the evidence was very low. This very low quality was mainly due to small
sample sizes, problems with study methods, and differences between trials. Therefore, although we found some evidence for a few
benefits of CCT for cognition, we were highly uncertain about study results and consider it likely that future research might lead to
different results.
Our conclusions
Unfortunately, it is not yet possible to answer our review question with any certainty. We think it remains an important area for further
study. We would like to see larger studies, which would be more able to detect effects of CCT, and longer studies, which are needed
to show whether there are any benefits, whether benefits are long-lasting, and whether there is a chance of preventing or delaying the
development of dementia.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Computerised cognitive training compared with active control in people with mild cognitive impairment
Patient or population: pat ients with mild cognit ive impairment
Settings: general populat ion
Intervention: computerised cognit ive training
Comparison: act ive control
Outcomes Differences between CCT and
control (95% CI)∗
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Global cognit ive funct ioning
(follow-up ranging f rom 3 months
up to 2 years)
SMD 0.53 lower
(1.06 lower to 0.01 lower)
407 part icipants
(5 studies)
⊕©©©
very lowb
It is uncertain whether CCT main-
tains global cognit ive funct ioning bet-
ter than act ive control
Episodic memory
(follow-up ranging f rom 3 months
up to 2 years)
SMD 0.79 lower
(1.54 lower to 0.04 lower)
223 part icipants
(5 studies)
⊕©©©
very lowb
It is uncertain whether CCT improves
episodic memory compared to act ive
control
Speed of processing
(follow-up ranging f rom 3 months
up to 2 years)
SMD 0.20 higher
(0.16 lower to 0.56 higher)
119 part icipants
(2 studies)
⊕⊕©©
lowc
CCT may have lit t le or no ef fect on
speed of processing
Execut ive funct ioning
(follow-up ranging f rom 3 months
up to 2 years)
SMD 0.31 lower
(0.90 lower to 0.28 higher)
150 part icipants
(3 studies)
⊕©©©
very lowb
It is uncertain whether CCT improves
execut ive funct ioning better than ac-
t ive control
Working memory (follow-up rang-
ing f rom 3 months up to 9 months)
SMD 0.88 lower
(1.73 lower to 0.03 lower)
72 part icipants
(3 studies)
⊕©©©
very lowd
It is uncertain whether CCT improves
working memory compared to act ive
control
Verbal f luency (follow-up ranging
f rom 3 months up to 18 months)
SMD 0.16 lower
(0.76 lower to 0.44 higher)
150 part icipants
(3 studies)
⊕⊕©©
lowc
CCT may have lit t le or no ef fect on
speed of processing
Quality of lif e
(3 months of follow-up)
MD 0.40 higher
(1.85 higher to 2.65 lower)
19 part icipants
(1 study)
⊕⊕©©
lowc
CCT may have lit t le or no ef fect on
quality of lif e
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* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CCT: computerised cognit ive training; CI: conf idence interval; MD: mean dif ference; RR: risk rat io; SMD: standardised mean dif ference
GRADE Working Group grades of evidence.
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
aThe direct ion of the dif ference in ef fect was standardised, so that lower values favour CCT and higher values favour control.
bDowngraded three levels for imprecision (conf idence interval included ef fects that are not clinically relevant), inconsistency
(high heterogeneity), and risk of bias.
cDowngraded two levels for imprecision (conf idence interval included ef fects that are not clinically relevant) and risk of bias.
dDowngraded four levels for imprecision (conf idence interval included ef fects that are not clinically relevant), inconsistency
(high heterogeneity), indirectness, and risk of bias.
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B A C K G R O U N D
Description of the condition
Mild cognitive impairment
Normal ageing is associated with decline in many core cognitive
functions (Salthouse 2003). When cognition deteriorates beyond
normal age-related change, but the ability to complete ordinary
activities of daily function remains largely intact, the condition is
described as mild cognitive impairment (MCI). In some people,
MCI is an intermediate state on the pathway from normal cog-
nition to dementia. When several cognitive domains are involved
and function in daily activities has deteriorated significantly, the
diagnosis is changed to that of dementia. However, there is no
clear demarcation between normal cognition and mild cognitive
impairment, or between mild cognitive impairment and demen-
tia, and it is impossible to identify the specific points of conversion
(Aisen 2011; Albert 2011).
One review identified 16 different classification and measurement
approaches for MCI (Matthews 2008); there remains no standard
definition of MCI accepted for use in clinical trials (Stephan 2013).
The National Institute on Aging (NIA)-Alzheimer’s Association
published criteria for MCI in 2011 (Albert 2011), but the criteria
suggested earlier by Petersen are still commonly used in clinical
research (Petersen 1999). Clinical subtypes have been introduced
based on the presence or absence of a primary memory impairment
(amnestic or non-amnestic MCI), and on the number of cognitive
domains affected (single domain or multiple domains) (Petersen
2009; Winblad 2004). Further subdivisions can be made depend-
ing on the suspected underlying cause of cognitive deficits, for ex-
ample, MCI due to Alzheimer’s disease (MCI-AD) and MCI due
to vascular disease (also termed ’vascular cognitive impairment no
dementia’ (VCIND)). The term ’mild neurocognitive disorder’ is
broadly synonymous with MCI.
The prevalence of MCI is more than double than that of dementia
(Petersen 2009). A recent review suggests a prevalence of MCI of
6.7% in those aged 60 to 64 years, increasing to 25.2% among
those aged 80 to 84 (Petersen 2018). However prevalence rates
vary depending on the diagnostic criteria used. When 18 different
definitions of MCI were mapped, prevalence estimates were found
to range from 0.1% to 42%, and ’conversion’ rates to dementia
were found to be generally low (Stephan 2007). Prevalence and
conversion rates in specialist settings are higher than those ob-
served in population-based studies, with the adjusted annual con-
version rate from MCI to dementia of 9.6% in specialist settings
compared to 4.9% in the general population (Mitchell 2009). A
large number of individuals with a diagnosis of MCI do not go on
to develop dementia, and between 14% and 40% revert to normal
cognitive function for their age (Koepsell 2012). Mild cognitive
difficulties in themselves have functional and psychological rami-
fications for quality of life (Mitchell 2009).
Dementia
Dementia is usually a progressive syndrome of cognitive and func-
tional decline. Although most commonly associated with ’forget-
fulness’, dementia, by definition, involves impairments in more
than one cognitive domain, and impairments in language, exec-
utive function, complex attention, and social cognition are com-
monly identified. As the syndrome progresses, those affected be-
come increasingly dependent on care from others for all activities
of daily living (e.g. feeding, bathing, taking medication). Demen-
tia is one of the principal causes of disease, disability, and decreased
quality of life among older adults and is now identified as one
of the biggest global health challenges. It may affect up to 135
million adults worldwide by 2050 (Prince 2013). The global eco-
nomic cost of care for people with dementia is currently estimated
at $315 billion (Wimo 2010).
Dementia is sometimes referred to as a neurocognitive disorder,
as in the Diagnostic and Statistical Manual of Mental Disorders,
5th Edition (DSM-V; APA 2013); the two terms may be used
interchangeably. Subtypes of dementia are distinguished by the
underlying brain pathology. The four most common subtypes of
dementia include:
• dementia due to Alzheimer’s disease (AD), which accounts
for an estimated 60% to 70% of all dementia cases;
• vascular dementia (VaD);
• dementia with Lewy bodies (DLB); and
• frontotemporal dementia (FTD).
Accurate diagnosis of subtypes can be difficult, especially when the
clinical disease is severe. Mixed pathology is commonly reported,
with more than 80% of cases having some features of AD (Jellinger
2006; WHO 2012).
Alzheimer’s disease (AD), the most common cause of dementia, is
now known to have a long prodromal period. In those with AD,
MCI - the symptomatic pre-dementia phase - offers an oppor-
tunity to introduce interventions that may prevent or postpone
the onset of clinical dementia (Leifer 2003). Delaying progression
from MCI to dementia would lead to a reduction in the incidence
of dementia, with a significant reduction in associated costs to so-
ciety and improved quality of life for individuals. Postponement
of dementia onset by five years may reduce prevalence by 50%
(Brookmeyer 1998). No drugs are currently available that can re-
duce the risk of progression from MCI to dementia (Russ 2012).
As a result, investigations are focusing on non-pharmacological
interventions that may delay clinical progression (Acevedo 2007;
Dresler 2013).
Risk and protective factors for MCI and dementia
Age is the strongest risk factor for dementia. However, research has
identified several additional risk and protective factors linked with
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late-onset dementia in general and with AD in particular (World
Alzheimer Report 2014). The World Health Organization 2017
Dementia Action Plan reports that reducing such risks is a major
health objective to reduce disability (who.int/mental_health/neu-
rology/dementia/action_plan_2017_2025/en/). Epidemiological
evidence suggests that AD shares many risk factors with vascular
dementia; these include cerebrovascular disease, type 2 diabetes,
midlife obesity, midlife hypertension, smoking, and physical inac-
tivity (Pendlebury 2009; WHO 2012; World Alzheimer Report
2014). It has recently been suggested that, after non-independence
between risk factors is accounted for, around a third of AD cases
worldwide might be attributable to potentially modifiable risk fac-
tors (Norton 2014), including alcohol intake, depression, diet,
physical exercise, education, and mental activity (Barnes 2011; de
Bruijn 2013; Diniz 2013; Erickson 2011; Jorm 2001). Lifestyle
factors could increase or decrease risk of dementia (Amoyal 2012;
Karp 2006).
Mental activity has been identified as a potentially important pro-
tective factor. Epidemiological studies indicate that lifelong cog-
nitively stimulating experiences, including education and occupa-
tion and leisure activities, are linked to improved late-life cogni-
tion, reduced risk of cognitive decline, and lower incidence of AD
(Barnes 2011; Marioni 2014; Verghese 2003; Wilson 2002). Lack
of education has been identified in meta-analyses as a particularly
strong predictor of dementia (Beydoun 2014). However, prospec-
tive studies indicate that even when mental activity is commenced
late in life, it may have positive effects on cognition, with lowered
rates of decline and lowered dementia incidence reported (Geda
2012; Wilson 2010; Wilson 2012). Cognitively stimulating activ-
ity may therefore offer an opportunity to maintain cognitive func-
tion, or to prevent or delay further deterioration, among those in
early stages of cognitive decline.
Description of the intervention
This review focuses on randomised controlled trials (RCTs) in-
vestigating the effects of computerised cognitive training (CCT)
interventions for maintenance of cognition and prevention of
dementia in people with mild cognitive impairment. ’Cognitive
training’ has been operationally defined as an intervention con-
sisting of repeated practice on standardised cognitive exercises tar-
geting specific cognitive domains for the purpose of stimulating
cognitive function (Gates 2010; Gates 2014; Kueider 2012). Al-
though cognitive training may include traditional pen and paper
tasks, it more commonly takes the form of computer-based tasks,
including exercises, games, and virtual reality. Computerised cog-
nitive training may be delivered in individual sessions or within
groups, with supervision or privately at home.
How the intervention might work
The underlying premise of cognitive training is that intensive cog-
nitive exercises may build up or restore brain and cognitive reserve,
providing greater resilience against neuropathology and maintain-
ing function (Liberati 2012). ’Brain reserve’ refers to structural
tolerance of the brain to disease and may be evident in increased
brain volume; ’cognitive reserve’ refers to functional differences in
neural activity and cognitive processes (Sterne 2012). Up to 33%
of individuals functioning independently without clinical demen-
tia have the same volume of disease pathology as those with clini-
cal dementia (Neuropathology Group 2001). The concept of re-
serve provides a theoretical explanation for the differences between
those who succumb to AD pathology and develop clinical de-
mentia, and those who tolerate the disease and maintain function
(Sterne 2012). It has been further suggested that cognitive stim-
ulation may result in neural plasticity and neural compensation,
that is, in the development of compensatory networks maintain-
ing cognitive performance and potentially masking or preventing
the clinical manifestation of neurocognitive disease (Grady 2012;
Park 2013).
Although the evidence base is very limited, some human trials of
cognitive training have suggested positive neuroplastic changes.
Diverse changes have been reported, including neurochemical ac-
tivation (Olesen 2004; Rosen 2011), altered fluorodeoxyglucose
uptake (Belleville 2012), and reduced β-amyloid burden (Landau
2012). Several diverse studies investigating neurophysiological
changes seen on functional magnetic resonance imaging (fMRI)
have identified increased prefrontal and parietal activity and hip-
pocampal activation (Olesen 2004; Rosen 2011; Suo 2012a;
Valenzuela 2003). Electroencephalography (EEG) and magnetic
resonance spectrometry (MRS) studies of cognitive training sup-
port the concept of functional neural plasticity post training, with
results indicating positive changes in brain metabolism, task-de-
pendent brain activation, and resting-state networks (Belleville
2012; Berry 2010; Förster 2011). However, the research is limited,
and significant further investigation is required.
Why it is important to do this review
The potential of CCT to be an effective intervention to main-
tain cognitive function, or to reduce the risk of clinical dementia,
along with its low implementation costs and its high availabil-
ity and accessibility, has led to the American Alzheimer’s Associa-
tion recommending rapid development and testing of such train-
ing (Alzheimer’s Association 2014). However, the evidence base
to date has been inconclusive, with mixed results reported. Sev-
eral prior reviews exist, but these include mixed populations and
varied interventions, and they need to be updated (Bahar-Fuchs
2013; Martin 2011). Earlier reviews have been critical of clinical
trials for poor specification of interventions, small sample sizes,
failure to assign treatments randomly, and lack of longitudinal
follow-up - all factors that may contribute to heterogeneous re-
sults (Gates 2010; Gates 2014; Kueider 2012; Mowszowski 2010;
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Papp 2009; Reijnders 2013; Walton 2014). Additional method-
ological criticisms with an impact upon valid evaluation of cogni-
tive training include lack of differentiation between interventions,
lack of adequate control conditions to isolate intervention benefit,
a limited number of trials with active controls, and limited out-
come measures to determine generalisation to non-trained cogni-
tive domains and persistence of benefits (Gates 2010; Green 2014;
Mowszowski 2010; Park 2013; Walton 2014). Primary studies
have identified that the benefits of cognitive training may depend
upon several factors including age, cognitive level, and non-cog-
nitive factors (Lampit 2014; Stine-Morrow 2014). Therefore a ro-
bust review is warranted to investigate the efficacy of computerised
cognitive training for people with MCI on non-trained cognitive
domains, and to evaluate potential sources of bias and hetero-
geneity in the literature. If sufficient trials are identified, then it
is important to examine the intervention characteristics and other
factors that may affect outcomes.
There has been a proliferation of commercial brain training prod-
ucts purporting to improve cognitive function and reduce demen-
tia risk. For older people, fear of cognitive decline and demen-
tia may be a powerful motivator to seek such preventive inter-
ventions. However the development of such programmes has fre-
quently outpaced thorough research into product benefits (Gates
2014; Lampit 2015). The World Alzheimer Report 2014 has re-
ported that cognitively stimulating activities, including reading,
playing musical instruments, and playing cards and board games,
may be beneficial for improving and maintaining while preventing
decline in cognitive functioning, although most of these activities
have not been investigated in clinical trials. In this context of con-
fusing and potentially misleading claims, this review is important
to provide potential consumers with information on how best to
spend time, effort, and money they might invest to prevent cog-
nitive decline.
As well as informing individuals, the findings of this review may be
useful to public health decision-making bodies, healthcare prac-
titioners, and researchers, providing them with a comprehensive
synthesis of information about the current state of the evidence,
and identifying research gaps and unanswered questions in the
field.
We also refer readers to companion reviews on the effects of com-
puterised cognitive training on healthy people at midlife and in
late life (Gates 2019a; Gates 2019b).
O B J E C T I V E S
To evaluate the effects of at least 12 weeks of computerised cogni-
tive training (CCT) on maintaining or improving cognitive func-
tion and preventing dementia in people with mild cognitive im-
pairment.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) and quasi-RCTs,
published or unpublished, reported in any language. Full reports
and other types of reports, such as conference abstracts, were eligi-
ble for inclusion. We included studies involving both randomised
and non-randomised trial arms but considered only results from
the former. We included cross-over studies but extracted and anal-
ysed data from the first treatment period only.
Types of participants
We included studies of people with a diagnosis of mild cognitive
impairment (MCI) or mild neurocognitive disorder (MND), or
from a population at high risk of cognitive decline.
We accepted diagnoses of MCI, MND, and risk of cognitive de-
cline made by the authors of each clinical trial and recorded the
definitions used. These could include diagnostic assessment and/
or subjective memory complaints with reduced scores on cogni-
tive tests such as the Mini Mental State Examination. In all cases,
an attempt should have been made by the trial authors to exclude
dementia, and it was acceptable for the purpose of excluding de-
mentia for a study to have used a cognitive score cut-off. Again,
we accepted whatever cut-off study authors used, and we explored
this as a possible source of heterogeneity.
We excluded studies of adults with a diagnosis of dementia, any
other neurological condition, or psychiatric illness.
We contacted study authors if we needed clarification to determine
health status. If we received no response, clinical experts in our
review group classified the trials or listed them as ’Studies awaiting
classification’.
Types of interventions
We included studies that compared cognitive training interven-
tions using interactive computerised technology versus active or
inactive control interventions over at least 12 weeks.
Experimental interventions had to adhere to the following crite-
ria: any form of interactive computerised cognitive intervention,
including computer exercises, computer games, mobile devices,
gaming console, and virtual reality, that involve repeated practice
on standardised exercises including a specified cognitive domain
or domains, for the purpose of enhancing cognitive function.
By ’active control’, we mean all those control conditions that in-
volve unguided computer- and/or screen-based tasks that are not
planned as interventions. These tasks can involve watching educa-
tional videos or playing computer games with no particular train-
ing component. By ’inactive control’, we refer to control groups
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for which no intervention is applied that may be expected to have
an effect on cognition.
The minimum treatment duration was set at 12 weeks, and all
included trials had to report outcomes at a minimum of one time
point 12 or more weeks after randomisation. To evaluate the ef-
fects of training on meaningful long-term outcomes, it was nec-
essary to make a judgement about the minimum ’dose’ of train-
ing that may be required to effect an enduring change. Previous
research suggests that acute brain changes can be seen following
eight weeks of training (Engvig 2014), but we are unable to find
any evidence that such brain changes persist. Most studies exam-
ining the benefits of brain and cognitive reserve identify long-term
cognitive stimulation from years of education. We therefore made
an arbitrary judgement that at least 12 weeks of regular cognitive
training would be required for intervention to have an enduring
effect. Addtionally, this time frame is consistent with recommen-
dations from reviews of clinical trials (Lampit 2014a). It is recog-
nised that the relationship between short-term cognitive training
effects and maintenance of cognitive function over longer periods
of time is unclear.
We excluded interventions that did not involve any form of com-
puter delivery. We also excluded studies where researchers com-
bined the experimental intervention with any other form of in-
tervention, unless the added intervention was provided in a stan-
dardised manner to both experimental and control groups.
Types of outcome measures
Primary outcomes
Primary outcomes included the following.
• Incidence of all-cause dementia (measured as a
dichotomous outcome).
• Global cognitive function (measured as a continuous
outcome).
Global cognitive functioning could be measured using any vali-
dated tests, for example (but not limited to):
• Alzheimer’s Disease Assessment Scale - Cognitive subscale
(ADAS-Cog);
• Mini Mental State Examination (MMSE);
• Repeatable Battery for Assessment of Neuropsychological
Status (RBANS); and
• Cambridge Cognition Examination (CAMCOG).
The main time point of interest was ’end of trial’, defined as the
time point with the longest period of follow-up from randomi-
sation (see also section Data collection and analysis). We also ex-
tracted and presented outcome data reported at other time points
after randomisation.
Secondary outcomes
Secondary outcomes included the following.
• Cognitive tests not included in the training programme,
administered before and after training, that are any validated
measure of:
◦ episodic memory;
◦ executive functioning;
◦ speed of processing;
◦ attention/working memory; or
◦ verbal fluency.
• Quality of life/psychological well-being, either generic or
disease-specific.
• Daily function, such as measures of instrumental activities
of daily living.
• Number of participants experiencing one or more serious
adverse events.
If a trial provided data on more than one cognitive scale for a
specific outcome, we applied a predetermined hierarchy of cog-
nitive outcome scales and used data on the cognitive scale that
was highest on this hierarchy. For example, if a trial reported re-
sults on both the Mini Mental State Examination and the Clinical
Dementia Rating scale (CDR), we used outcome data from the
MMSE in our quantitative analyses. The order of a scale in the
hierarchy was determined by the frequency of its use in a large
set of 79 trials, evaluating vitamin and mineral supplementation,
dietary interventions, and physical exercise interventions.
Outcomes included in the ’Summary of findings’ table
We addressed critical effectiveness outcomes in a ’Summary of
findings’ table for each comparison. We planned to include all
outcomes related to cognitive function on non-trained tasks and
quality of life. For the comparison CCT versus active control, we
were able to include the following outcomes: (1) global cognitive
functioning, (2) episodic memory, (3) speed of processing, (4) ex-
ecutive functioning, (5) working memory, (6) verbal fluency, and
(7) quality of life. For the comparison CCT versus inactive control,
we were able to include the following outcomes: (1) global cogni-
tive functioning, (2) episodic memory, (3) executive functioning,
(4) verbal fluency, (5) depression, and (6) functional performance.
Search methods for identification of studies
Electronic searches
We searched ALOIS ( www.medicine.ox.ac.uk/alois) - the spe-
cialised register of the Cochrane Dementia and Cognitive Im-
provement Group - up to 31 May 2018.
The Information Specialist for the CDCIG maintained ALOIS,
which contains studies that fall within the areas of dementia pre-
vention, dementia treatment and management, and cognitive en-
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hancement in the healthy elderly populations. These studies are
identified through:
• monthly searches of several major healthcare databases:
MEDLINE, Embase, the Cumulative Index to Nursing and
Allied Health Literature (CINAHL), PsycINFO, and Latin
American Caribbean Health Sciences Literature (LILACS);
• monthly searches of several trial registers: the University
hospital Medical Information Network Clinical Trials Registry (
Japan) ( UMIN-CTR) ( www.umin.ac.jp/ctr/index.htm); the
World Health Organization ( WHO) portal ( which covers
ClinicalTrials.gov ( clinicaltrials.gov/); International Standard
Randomized Controlled Trials Number ( ISRCTN) (
www.isrctn.com/); the Chinese Clinical Trials Register (
ChiCTR) ( who.int/ictrp/network/chictr/en/); the German
Clinical Trials Register ( GermanCTR) ( who.int/ictrp/network/
drks2/en/); the Iranian Registry of Clinical Trials ( IRCT) (
who.int/ictrp/network/irct2/en/); and the Netherlands National
Trials Register ( NTR) ( who.int/ictrp/network/ntr/en/), plus
others);
• quarterly searches of the Central Register of Controlled
Trials, in the Cochrane Library (CENTRAL); and
• six-monthly searches of several grey literature sources:
Institute for Scientific Information (ISI) Web of Knowledge
Conference Proceedings; Index to Theses; Australasian Digital
Theses.
To view a list of all sources searched for ALOIS, see About ALOIS
on the ALOIS website ( www.medicine.ox.ac.uk/alois).
Details of the search strategies run in healthcare bibliographic
databases, used for retrieval of reports of dementia, cognitive im-
provement, and cognitive enhancement trials, can be viewed in
the ‘Methods used in reviews’ section within the editorial informa-
tion about the Cochrane Dementia and Cognitive Improvement
Group.
We conducted additional searches in MEDLINE, Embase,
PsycINFO, CINAHL, ClinicalTrials.gov, and the WHO Por-
tal/International Clinical Trials Registry Platform ( ICTRP) (
www.apps.who.int/trialsearch), to ensure that the searches were as
comprehensive and as up-to-date as possible. The search strategies
used are shown in Appendix 1.
Searching other resources
We screened the reference lists of all included trials. In addi-
tion, we screened the reference lists of recent systematic reviews,
health technology assessment reports, and subject-specific guide-
lines identified through www.guideline.gov. We restricted the
search to those guidelines meeting National Guideline Clearing-
house (NGC) 2013 published inclusion criteria.
We contacted experts in the field and companies marketing in-
cluded interventions to request additional randomised trial reports
not identified by the search.
Data collection and analysis
We used the protocol for this review alongside instructions for
data extraction, quality assessment, and statistical analyses gen-
erated by the editorial board of CDCIG, and based in part on
a generic protocol approved by the Cochrane Musculoskeletal
Group for another series of reviews (da Costa 2012; da Costa 2014;
Reichenbach 2010; Rutjes 2009a; Rutjes 2009b; Rutjes 2010).
Selection of studies
If multiple reports described the same trial, we included all of them
to allow extraction of complete trial details.
We used crowdsourcing to screen the search results. Details of this
approach have been described at www.medicine.ox.ac.uk/alois/
content/modifiable-risk-factors. In brief, teams of volunteers per-
formed a ’first assess’ on the search results. The crowd was re-
cruited through the network called Students For Best Evidence
( www.students4bestevidence.net). The crowd provided an ini-
tial screen of the results using an online tool developed for the
Cochrane EMBASE project, but tailored for this programme of
work. The crowd decided (based on reading of title and ab-
stract) whether the citation was describing a randomised trial or a
quasi-randomised trial, irrespective of the citation topic. We then
screened the remaining results (titles and abstracts). Four inde-
pendent review authors (NG, EM, SK, RV) assessed the full text
of studies for eligibility, with any disagreements resolved by a fifth
independent review author.
We recorded the selection process in sufficient detail to complete
a PRISMA flow diagram and Characteristics of excluded studies
table (Moher 2009). We did not impose any language restrictions.
Data extraction and management
Five review authors (NG, MN, SK, RV, AR), working indepen-
dently, extracted trial information using a standardised and pi-
loted extraction method, referring also to a guidance document,
and resolving discrepancies by discussion, or by involvement of
an independent review author. Where possible, we extracted the
following information related to characteristics of participants, in-
terventions, and study design.
Participant characteristics
• Gender
• Age (range, median, mean)
• Education (level and years of education)
• Baseline cognitive function
• Cognitive diagnostic status
• Duration of cognitive symptoms
• Ethnicity
• Apo-E genotype
• Vascular risk factors (hypertension, diabetes,
hyperlipidaemia)
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• Body mass index (BMI)
• Depression and stress
• Physical activity
• Work status
Intervention characteristics
• Type and description of cognition-based intervention
• Type and description of the control condition
• Delivery mode (individualised, group intervention,
supervision)
• Length of training sessions (intensity)
• Frequency of sessions per week (dose)
• Duration of treatment programme
• Presence of supervision
• Group or individual
• Any concomitant treatments
Methodological characteristics
• Trial design (individual or cluster randomisation; parallel-
group, factorial, or cross-over design)
• Number of participants
• Outcome measures used
• Duration of follow-up as measured from randomisation
• Duration of follow-up as measured from end of treatment
• Source of financial support
• Publication status
If outcome data were available at multiple time points within a
given trial, we extracted data at 12 weeks, along with short-term
(up to one year), medium-term (one to two years), and long-term
results (more than two years). Within these time periods, we ex-
tracted the latest data reported by the study (e.g. if the study reports
data at six months, nine months, and one year, we extracted only
the one-year data, and we analysed these for the one-year (short-
term) time point). For dichotomous outcomes (such as number of
participants experiencing one or more serious adverse events), we
extracted from each trial the number of participants with each out-
come at each time point. For continuous outcomes, we extracted
the number of participants for whom the outcome was measured,
as well as the mean and standard deviation (SD) of the change
from baseline for each outcome at each time point. If change from
baseline data were not available, we extracted the mean value at
each time point. When necessary and possible, we approximated
means and measures of dispersion from figures in the reports. For
cross-over trials, we extracted data on the first treatment period
only. Whenever possible, we extracted intention-to-treat data (i.e.
analysing all participants according to the group randomisation);
if this information was not available, we extracted and reported
data from available case analyses. If none of these data were avail-
able, we considered data from per-protocol analyses. We contacted
the trial authors if we could not obtain necessary data from the
trial report.
Assessment of risk of bias in included studies
After completion of a standardised training session provided by
AR, one member of the review author team and one experi-
enced review author provided by the editorial team indepen-
dently assessed the risk of bias in each of the included trials, us-
ing Cochrane’s ’Risk of bias’ tool (Higgins 2011), and resolved
disagreements by consensus. We assessed the risk of bias poten-
tially introduced by suboptimal design choices with respect to se-
quence generation, concealment of allocation, blinding of partic-
ipants and caregivers, blinded outcome assessment, selective out-
come reporting, and incomplete outcome data, including the type
of statistical analysis used (true intention-to-treat vs other). Based
on the aforementioned criteria, we rated the studies as ’low risk’,
’unclear risk’, or ’high risk’ of bias for each domain, including a
description of the reasoning for our rating. The general definitions
used are reported in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011). We derived review-specific defini-
tions in part from a previously published systematic review (Rutjes
2012), and we have explained them in detail in Appendix 2.
Measures of treatment effect
The measure of treatment effect for continuous outcomes was an
effect size (standardised mean difference), defined as the between-
group difference in mean values divided by the pooled SD. In case
a single trial contributed to a comparison, or if all studies used
the same instrument, we used the mean difference to describe and
analyse results. We expressed the treatment effect for dichotomous
outcomes as a risk ratio (RR) with a 95% confidence interval (CI).
Unit of analysis issues
We identified no cluster-randomised trials for inclusion. We in-
cluded one cross-over study, but we extracted and analysed data
from the first treatment period only.
Dealing with missing data
Missing data in the individual trials may put study estimates of
effects at high risk of bias and may lower the overall quality of
evidence according to the Grading of Recommendations Assess-
ment, Development, and Evaluation ( GRADE) Working Group
( www.gradeworkinggroup.org). We dealt with missing data in
our ’Risk of bias’ assessments and planned evaluation of attrition
bias in stratified analyses of the primary outcomes (Appendix 2;
Differences between protocol and review). We analysed available
information and did not contact study authors with a request to
provide missing information, nor did we impute missing data our-
selves.
Assessment of heterogeneity
We planned to examine between-trial heterogeneity in stratified
analyses by trial, participant, and intervention. As the number
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of trials identified was too small to permit meaningful analyses,
we refrained from performing such analyses (Differences between
protocol and review). We visually inspected forest plots for the
presence of heterogeneity and calculated the variance estimate tau²
as a measure of between-trial heterogeneity (DerSimonian 1986).
We prespecified a tau² of 0.04 to represent low heterogeneity, 0.09
to represent moderate heterogeneity, and 0.16 to represent high
heterogeneity between trials (Spiegelhalter 2004). In addition, we
used the I² statistic and the corresponding Chi² test to assist read-
ers more familiar with these statistics (Higgins 2011). I² describes
the percentage of variation across trials attributable to heterogene-
ity rather than to chance, with values of 25%, 50%, and 75% in-
terpreted as low, moderate, and high ( respectively) between-trial
heterogeneity. We preferred tau² over I² in interpreting between-
trial heterogeneity, as interpretation of I² can be largely affected
by the precision of trials included in the meta-analysis ( Rcker
2008). All P values are two-sided.
Assessment of reporting biases
We did not identify enough trials to construct funnel plots to
explore reporting biases and other biases related to small-study
effects (Differences between protocol and review).
Data synthesis
We reported summary and descriptive statistics (means and SDs)
for participant and intervention characteristics.
We used standard inverse-variance random-effects meta-analysis
to combine outcome data across trials at end of trial (DerSimonian
1986), and, if possible, at least one additional time point (see
Primary outcomes and Data collection and analysis for definitions
of time points). We conducted statistical analyses in Review Man-
ager 5 (RevMan 2014) and in STATA, release 14 (Statacorp, Col-
lege Station, Texas, USA).
GRADE and ’Summary of findings’ tables
We used GRADE to describe the quality of the overall body of
evidence for each outcome in the ’Summary of findings’ tables
(Guyatt 2008; Higgins 2011). We defined quality as the degree of
confidence that we can place in the estimates of treatment benefits
and harms. There were four possible ratings: high, moderate, low,
and very low. Rating evidence as ’high quality’ implies that we are
confident in our estimate of the effect and further research is very
unlikely to change this. A rating of ’very low’ quality implies that
we are very uncertain about the obtained summary estimate of the
effect. The GRADE approach rates evidence from RCTs that do
not have serious limitations as ’high quality’. However, several fac-
tors can lead to downgrading of the evidence to ’moderate’, ’low’,
or ’very low’. The degree of downgrading is determined by the se-
riousness of these factors: study limitations (risk of bias); inconsis-
tency; indirectness of evidence; imprecision; and publication bias
(Guyatt 2008; Higgins 2011).
Subgroup analysis and investigation of heterogeneity
We did not identify enough trials to conduct subgroup analyses.
Sensitivity analysis
For the primary outcome, we performed one sensitivity analysis,
including only those trials that used an internationally accepted
definition of MCI.
R E S U L T S
Description of studies
See Characteristics of included studies, Characteristics of excluded
studies, Characteristics of studies awaiting classification, and Char-
acteristics of ongoing studies.
Results of the search
We conducted searches in January 2015, July 2015, February
2016, July 2016, and May 2018. In total, we retrieved 8392 records
through the five searches. After de-duplication, 6233 records re-
mained. A crowd and the CDCIG Information Specialist assessed
these records at the title and abstract level. In total, 1091 results
remained after this assessment. We then screened these records.
Of these, we assessed 321 full-text articles for eligibility, and we
included eight studies in the review (Barnes 2013; Djabelkhir
2017; Fiatarone Singh 2014; Gooding 2016; Herrera 2012; Kwok
2013a; Optale 2010; Rozzini 2007). We have depicted this pro-
cess in Figure 1.
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Figure 1. Study flow diagram.
13Computerised cognitive training for preventing dementia in people with mild cognitive impairment (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Included studies
We have provided study details in the Characteristics of included
studies section and have briefly summarised them below. We in-
cluded in this review eight studies with a total of 660 participants.
Design
All studies are RCTs, with seven comparing CCT versus an active
control and one versus an inactive control condition.
Study durations were 12 weeks (Kwok 2013a), three months (
Barnes 2013; Djabelkhir 2017), four months (Gooding 2016), six
months (Optale 2010), nine months (Herrera 2012), 12 months
(Rozzini 2007), and 18 months (Fiatarone Singh 2014).
Sample size
Barnes 2013 randomised 126 participants to four different treat-
ment arms (including one control arm), each with 31 or 32 par-
ticipants. Djabelkhir 2017 randomised 10 participants to the ex-
perimental arm and 10 to the control arm. Fiatarone Singh 2014
randomised 51 participants to the experimental arms and 49 to
the control arms. Gooding 2016 randomised 96 participants to
the three arms of interest (the number of participants randomised
to each arm is not reported). Herrera 2012 randomised 11 partic-
ipants to both intervention and control groups. Kwok 2013a was
the largest trial, with 111 participants randomised to the experi-
mental arm and 112 to the control arm. Optale 2010 randomised
18 participants to each of the intervention and control groups.
Finally, Rozzini 2007 randomised 15 participants to the interven-
tion group and 22 to the control group.
Setting
Barnes 2013 was conducted at a single centre in the USA.
Djabelkhir 2017 was conducted at a single centre in France.
Fiatarone Singh 2014 was conducted in Australia. Gooding 2016
was conducted at four different sites in the USA; Herrera 2012 at
a single centre in France; Kwok 2013a at six community centres
randomly chosen from three districts in Hong Kong; Optale 2010
at a single centre; and Rozzini 2007 at two centres in Italy.
Participants
Four studies included participants with established MCI at base-
line. Diagnostic criteria were consistent with Petersen criteria in
Djabelkhir 2017, Herrera 2012 (Petersen 2004 criteria), Fiatarone
Singh 2014 (Petersen 1999 criteria), and Rozzini 2007 (Petersen
2001 criteria). Optale 2010 included participants with a memory
deficit defined by a corrected total score below 15.76 on the Verbal
Story Recall (VSR) test. Barnes 2013, Gooding 2016, and Kwok
2013a included participants with self-reported or informant-re-
ported cognitive complaints at baseline and satisfied our inclu-
sion criteria, as participants had reduced scores on standardised
dementia screening tests.
The mean age of participants in experimental and control groups
ranged from 70 to 82 years. Rozzini 2007 gave an age range for
participants (63 to 78 years), and Gooding 2016 gave only the
median age for those who completed the study (76 years).
Interventions
Barnes 2013 used a 2 × 2 factorial design by which all participants
received computerised training (Posit Science software) (MA-I)
or active mental control educational videos (MA-C), along with
an exercise regimen (EX-I) or a sham exercise regimen (EX-C)
(Barnes 2013). We have included this study in comparison 1:
computerised cognition-based interventions versus active control.
Djabelkhir 2017 treated the intervention group with a comput-
erised multi-domain software programme (KODRO) and trained
the control group to use a tablet PC and stiimulate social interac-
tions among participants. We have included this study in compar-
ison 1: computerised cognition-based interventions versus active
control.
Fiatarone Singh 2014 used a 2 × 2 factorial design involving cog-
nitive training (CT) with Cogpack computer-based exercises or
sham cognitive training (watching educational videos followed by
a set of questions), as well as progressive resistance training (PRT)
or sham PRT (stretching and seated callisthenics exercises). We
included all participants receiving CT (Cogpack) in the experi-
mental group and all participants receiving sham CT in the active
control group. We included these data in comparison 1: comput-
erised cognition-based interventions versus active control.
Gooding 2016 included three study arms. One arm received
computerised cognitive training in the BrainFitness programme,
another arm received the same BrainFitness programme and a
motivational therapeutic milieu (not included in the analysis).
The third arm played computer games. We have included this
study in comparison 1: computerised cognition-based interven-
tions (BrainFitness programme only) versus active control.
Kwok 2013a provided 12 weekly sessions of computerised training
focused on attention, memory, and reasoning as the experimental
intervention. The control group received a series of health-related
educational lectures on prevention of mood disorder, heart disease,
diabetes, and stroke. We have included this study in comparison 1:
computerised cognition-based interventions versus active control.
Herrera 2012 allocated the intervention group to computerised
memory and attention task training programmed in Java, while
the control group participated in activities such as finding names
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of countries and corresponding capitals, organising a list of pur-
chases by categories, and finding similarities and differences. We
have included this study in comparison 1: computerised cogni-
tion-based interventions versus active control.
Optale 2010 provided virtual reality training as the experimental
intervention and music therapy as the control intervention. We
have included this study in comparison 1: computerised cognition-
based interventions versus active control.
Rozzini 2007 included three study arms. One arm received CT
through a computerised multi-domain software programme (TNP
software) plus a cholinesterase inhibitor; another arm received a
cholinesterase inhibitor only; and the third arm received neither
CT nor cholinesterase inhibitor treatment (not included in the
analysis). We have included data from the first two arms in com-
parison 2: computerised cognition-based interventions versus in-
active control.
Outcomes
Here we describe outcome measures addressing outcomes of inter-
est to our review that we included in one or more meta-analyses.
We refer to the Characteristics of included studies table for other
instruments reported by trial authors that we did not select for
any meta-analyses. We have described under Types of outcome
measures the method used to select outcome measures for inclu-
sion.
Primary outcomes
Global cognitive function
Eight studies measured global cognitive function as an outcome.
Four studies measured global cognitive functioning using the
MMSE (Djabelkhir 2017; Optale 2010; Rozzini 2007; with the
modified MMSE (mMMSE) used in Gooding 2016); Kwok
2013a used the Chinese equivalent of the Mattis Dementia Rating
Scale; and Fiatarone Singh 2014 used ADAS-Cog.
Barnes 2013 used a composite score change at three months to
measure global cognitive functioning. We could not include this
outcome in the meta-analyses (see Effects of interventions).
Secondary outcomes
Cognitive function subdomain: episodic memory
One study used the Rey Auditory Verbal Learning Test (RAVLT)
to measure episodic memory (Barnes 2013). Fiatarone Singh
2014 used the Wechsler Memory Scale (WMS) Logical Mem-
ory I (immediate) at 6 months and 18 months; Gooding 2016
used the WMS Logical Memory II (delayed). Optale 2010, and
Rozzini 2007 used non-specified story recall. Herrera 2012, and
Djabelkhir 2017 measured episodic memory using a list learning
task: the 16-Item free recall (FR) and cued recall (CR) test (16-
FR/CR test).
Cognitive function subdomain: executive functioning
Two studies used Trails B to measure executive functioning (Barnes
2013; Djabelkhir 2017).
Fiatarone Singh 2014 measured executive function on the Simi-
larities subtest of the Wechsler Adult Intelligence Scale-III (WAIS-
III) at 6 and 18 months; Optale 2010 used dual task performance
to measure executive functioning; and Rozzini 2007 measured ex-
ecutive functioning using Raven’s coloured matrices.
Cognitive function subdomain: speed of processing
Two studies used Trails A to measure speed of processing (Barnes
2013; Djabelkhir 2017).
Fiatarone Singh 2014 measured speed of processing using the Sym-
bol Digit Modality Test (SDMT) at 6 months and 18 months.
Cognitive function subdomain: verbal fluency
Several studies measured verbal fluency using letter verbal fluency
(number of words generated beginning with specified letters), in-
cluding Barnes 2013, which measured in one minute all the words
the attendee could remember, words not stated, one attempt;
Djabelkhir 2017, which measured in two minutes all the words
the attendee could remember, starting with the letter P, attempts
not stated; Fiatarone Singh 2014, which used the Controlled Oral
Words Association Test,(COWAT); Optale 2010, which measured
in one minute all the words the attendee could remember, starting
with the letters C, P, and S, attempts not stated; and Rozzini 2007,
which measured in one minute all the words the attendee could
remember, words not stated, attempts not stated.
Cognitive function subdomain: working memory
Three studies used the digit span to measure working memory:
Djabelkhir 2017 (WAIS, 4th edition), Herrera 2012 (not stated),
and Optale 2010 (WAIS procedure).
Quality of life/Psychological well-being
Two studies measured depression using the Geriatric Depression
Scale (Optale 2010; Rozzini 2007): Djabelkhir 2017 measured
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depression using the Goldberg Scale, and Gooding 2016 measured
depression using the Beck Depression Inventory.
Djabelkhir 2017 measured quality of life using the quality of life
scale for older French people.
Functional performance
Only three studies measured this outcome: Fiatarone Singh 2014
and Rozzini 2007 measured daily function with the BAYER -
Activities of Daily Living scale (B-ADL), and Optale 2010 used
the Activities of Daily Living - Function scale.
Number of participants experiencing one or more serious
adverse events
Optale 2010 reported mortality at six months.
Excluded studies
We excluded 312 full-text articles during the full-text screen-
ing. Of these, we excluded one because it focused on cogni-
tively healthy people in midlife (Corbett 2015), and we excluded
nine because they focused on cognitively healthy people in late
life (Desjardins-Crépeau 2016; Klusmann 2010; Lampit 2014;
Lampit 2015; Legault 2011; Leung 2015; Peretz 2011; Shatil
2013; Van het Reve 2014). Two other Cochrane reviews have in-
cluded these 10 studies (Gates 2019a; Gates 2019b). We excluded
195 reports that investigated an intervention because it was pro-
vided for less than 12 weeks or because it did not involve comput-
erised cognitive training; and we excluded 18 because the study
did not use an eligible study design. We identified no ongoing
trials in the trial registers or conference proceedings. One study is
awaiting classification because, at the time of the final search, it
was available only as a conference abstract from which eligibility
could not be determined (not clear how cognitive training was
delivered). Reasons for exclusion of studies can be found in the
Characteristics of excluded studies table.
Risk of bias in included studies
For details, please see Characteristics of included studies. Figure 2
and Figure 3 display study level and aggregate results of the risk
of bias assessments.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
One study has low risk of selection bias due to adequate random
sequence generation and allocation concealment (Fiatarone Singh
2014). Two studies have unclear risk of selection bias because allo-
cation concealment was not described in sufficient detail, although
the study authors described an adequate method for generating a
random sequence (Barnes 2013; Djabelkhir 2017). The remain-
ing studies did not describe any method for sequence generation
nor allocation concealment (Gooding 2016; Herrera 2012; Kwok
2013a; Optale 2010; Rozzini 2007); we also judged these studies
to be at unclear risk of selection bias.
Blinding
We considered Barnes 2013 to have high risk of performance bias
because participants were not blinded to the type of intervention.
However, both study personnel and outcome assessors were ade-
quately blinded to the study treatment; therefore we judged the
risk of detection bias to be low. We judged Fiatarone Singh 2014,
Djabelkhir 2017, and Herrera 2012 to have unclear risk of per-
formance bias for participants and high risk of performance bias
for personnel, who were not blinded. However, study authors de-
scribed adequate blinding of outcome assessors, giving these stud-
ies low risk of detection bias. We considered Kwok 2013a, Optale
2010, and Rozzini 2007 to be at high risk of performance bias due
to lack of blinding for participants and personnel, but at low risk
of detection bias as outcome assessors were adequately blinded.
Gooding 2016 did not blind participants nor physicians (high risk
of performance bias), and we identified unclear risk of detection
bias due to lack of information regarding blinding of outcome
assessors.
Incomplete outcome data
We considered six studies to be at low risk of attrition bias (Barnes
2013; Djabelkhir 2017; Fiatarone Singh 2014; Herrera 2012;
Kwok 2013a; Rozzini 2007). We judged risk of attrition bias to be
high in Gooding 2016 because 77% of randomised participants
were analysed. In Optale 2010, 83% of participants randomised
to the intervention arm and 89% randomised to the control arm
were analysed; we judged this to put the study at high risk of
attrition bias.
Selective reporting
We considered six studies to be at low risk of reporting bias (Barnes
2013; Djabelkhir 2017; Fiatarone Singh 2014; Gooding 2016;
Herrera 2012; Rozzini 2007). We judged the remaining two stud-
ies to be at high risk of reporting bias. Optale 2010 did not report
one outcome that was described as measured and Kwok 2013a
incompletely reported outcome data described as non-significant.
Other potential sources of bias
We identified no other sources of bias.
Effects of interventions
See: Summary of findings for the main comparison; Summary
of findings 2
Comparison 1: computerised cognition-based
interventions versus active control
See Summary of findings for the main comparison for the compar-
ison CCT versus active control. Although Barnes 2013 reported
eligible outcome data for all cognitive outcomes, we could not
include these data in our meta-analyses because the data were re-
ported as standardised mean changes (z-scores). Therefore, we re-
port these results separately.
Primary outcomes
Incidence of dementia
We found no data on the incidence of dementia.
Global cognitive function
Evidence on global cognitive function at end of trial (Analysis 1.1;
Figure 4) was very low quality, downgraded because of imprecision,
inconsistency, and risk of bias. Therefore we are very uncertain
of this result. Negative values favour the CCT group. Analysis of
global cognitive function at end of follow-up gives a standardised
mean difference (SMD) of -0.53 (95% confidence interval (CI) -
1.06 to -0.01; 5 studies; 407 participants). Results at individual
time points are as follows: immediate time point (12 weeks) SMD
-0.31 (95% CI -0.70 to 0.08; 4 studies; 356 participants); short-
term time point (12 weeks to one year) SMD -1.23 (95% CI -
1.89 to -0.56; 2 studies; 82 participants); and medium-term time
point (one to two years) SMD 0.16 (95% CI -0.23 to 0.55; 1
study; 100 participants).
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Figure 4. Forest plot of comparison: 1 Computerised cognition-based interventions versus active control,
outcome: 1.1 Global cognitive function.
Trial with outcome data not included in the meta-analyses
Barnes 2013 derived a composite score from six distinct cognitive
instruments at three months. Higher values indicated improve-
ment. Study authors reported there were no significant differences
between groups (P from interaction = 0.26). In the comparison
between groups also receiving sham exercise, the mean change in
z-score was 0.17 in the CCT group (95% CI 0.03 to 0.31) and
0.16 in the educational DVD group (95% CI 0.05 to 0.26). In
the comparison between groups also receiving aerobic exercise, the
mean z-score change was 0.22 in the CCT group (95% CI 0.12 to
0.33) and 0.08 in the educational DVD control group (95% CI
-0.004 to 0.17). Overall we deemed the quality of this evidence
to be very low (downgraded for imprecision, indirectness of the
study population, and risk of bias).
Sensitivity analyses
We conducted a prespecified sensitivity analysis including only
trials in which MCI was diagnosed on the basis of internationally
accepted diagnostic criteria. Two studies with 119 participants
contributed to this analysis (Djabelkhir 2017; Fiatarone Singh
2014). At our main time point of interest - end of trial - we found
no clear evidence of an effect of training: SMD 0.01 (95% CI -
0.51 to 0.52; Tau² = 0.05; I² = 29%). We considered this to be low-
quality evidence (downgraded for imprecision and risk of bias).
Secondary outcomes
Cognitive subdomain: episodic memory
Evidence regarding episodic memory at end of trial (Analysis 1.2;
Figure 5) was very low quality, downgraded because of imprecision,
inconsistency, and risk of bias. Therefore we are very uncertain
about this result. Negative values favour the CCT group. Analysis
at end of follow-up gives an SMD of -0.79 (95% CI -1.54 to -
0.04; 5 studies; 223 participants). Results at individual time points
are as follows: immediate time point (12 weeks) SMD -0.99 (95%
CI -1.80 to -0.19; 4 studies; 172 participants); short-term time
point (12 weeks to one year) SMD -1.39 (95% CI -2.35 to -0.44;
3 studies; 104 participants); and medium-term time point (one
to two years) SMD 0.02 (95% CI -0.37 to 0.41; 1 study; 100
participants).
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Figure 5. Forest plot of comparison: 1 Computerised cognition-based interventions versus active control,
outcome: 1.2 Episodic memory.
Trial with outcome data not included in the meta-analyses
Barnes 2013 reported outcome data on verbal learning and mem-
ory (RAVLT), number of words learned, as standardised mean
changes (z-scores) at three months. Higher values indicated im-
provement. Study authors reported no significant differences be-
tween groups (P from interaction = 0.38). In the comparison be-
tween groups receiving sham exercise, the mean change in z-score
was 0.13 in the CCT group (95% CI -0.11 to 0.37) and 0.33
in the educational DVD group (95% CI 0.09 to 0.58). In the
comparison between groups receiving aerobic exercise, the mean
change in z-score was -0.04 in the CCT group (95% CI -0.42
to 0.33) and 0.14 in the educational DVD control group (95%
CI -0.14 to 0.43). We judged the quality of this evidence to be
very low (downgraded for imprecision, indirectness of the study
population, and risk of bias).
Cognitive subdomain: speed of processing
Evidence regarding speed of processing at end of trial (Analysis
1.3) was low quality, downgraded because of imprecision and risk
of bias. Negative values favour the CCT group. Analysis at end
of follow-up gives an SMD of 0.20 (95% CI -0.16 to 0.56; 2
trials; 119 participants). This result is imprecise but indicates there
may be little or no difference in the speed of processing between
intervention and control groups. Results at individual time points
are as follows: immediate time point (12 weeks) SMD 0.11 (95%
CI -0.25 to 0.47; 2 studies; 119 participants) and medium-term
time point (one to two years) SMD 0.14 (95% CI -0.25 to 0.53;
1 study; 100 participants).
Trial with outcome data not included in the meta-analyses
Barnes 2013 reported outcome data on Trail Making test part A
as standardised mean changes (z-scores) at three months. Lower
values indicated improvement. Study authors reported no signif-
icant differences between groups (P from interaction = 0.24). In
the comparison between groups receiving sham exercise, the mean
change in z-score was -0.03 in the CCT group (95% CI -0.50 to
0.44) and -0.36 in the educational DVD group (95% CI -0.58
to -0.15). In the comparison between groups receiving aerobic ex-
ercise, the mean change in z-score was -0.36 in the CCT group
(95% CI -0.63 to -0.08) and -0.12 in the educational DVD con-
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trol group (95% CI -0.32 to 0.07). We judged the quality of this
evidence to be very low (downgraded for imprecision, indirectness
of the study population, and risk of bias).
Cognitive subdomain: executive function
Evidence regarding executive function at end of trial (Analysis
1.4) was very low quality, downgraded because of imprecision,
inconsistency, and risk of bias. Therefore we are very uncertain
about this result. Negative values favour the CCT group. Analysis
at end of follow-up gives SMD -0.31 (95% CI -0.90 to 0.28; 3
studies; 150 participants). Results at individual time points are as
follows: immediate time point (12 weeks) SMD -0.18 (95% CI -
0.50 to 0.14; 3 studies; 150 participants); short-term time point
(12 weeks to one year) SMD -0.81 (95% CI -1.54 to -0.07; 1 study;
31 participants); and medium-term time point (one to two years)
SMD 0.08 (95% CI -0.31 to 0.48; 1 study; 100 participants).
Trial with outcome data not included in the meta-analyses
Barnes 2013 reported outcome data on Trail Making test part B as
standardised mean changes (z-scores) at three months. Lower val-
ues indicated improvement. No differences between groups were
found (P from interaction = 0.31). In the comparison between
groups receiving sham exercise, the mean change in z-score was
0.13 in the CCT group (95% CI -0.21 to 0.48) and -0.22 in the
educational DVD group (95% CI -0.45 to 0.002). In the compar-
ison between groups receiving aerobic exercise, the mean change
in z-score was -0.25 in the CCT group (95% CI -0.51 to 0.01)
and -0.18 in the educational DVD control group (95% CI -0.49
to 0.13). We judged the quality of this evidence to be very low
(downgraded for imprecision, indirectness of the study popula-
tion, and risk of bias).
Cognitive subdomain: working memory
Evidence regarding working memory at end of trial (Analysis
1.5) was very low quality, downgraded because of imprecision,
inconsistency, indirectness, and risk of bias. Therefore we are very
uncertain about this result. Negative values favour the CCT group.
Analysis at end of follow-up gives SMD -0.88 (95% CI -1.73 to -
0.03; 3 studies; 72 participants). Results at individual time points
are as follows: immediate time point (12 weeks) SMD -0.66 (95%
CI -1.26 to -0.06; 3 studies; 72 participants) and short-term time
point (12 weeks to one year) SMD -1.29 (95% CI -1.88 to -0.69;
2 studies; 53 participants).
Cognitive subdomain: verbal fluency
Evidence regarding verbal fluency at end of trial (Analysis 1.6)
was low quality, downgraded because of imprecision and risk of
bias. Negative values favour the CCT group. Analysis at end of
follow-up gives SMD -0.16 (95% CI -0.76 to 0.44; 3 studies;
150 participants). Results at individual time points are as follows:
immediate time point (12 weeks) SMD -0.02 (95% CI -0.46 to
0.42; 3 studies; 150 participants), short-term time point (12 weeks
to one year) SMD -0.78 (95% CI -1.51 to -0.04; 1 study; 31
participants), and medium-term time point (one to two years)
SMD 0.17 (95% CI -0.22 to 0.57; 1 study; 100 participants).
Trial with outcome data not included in the meta-analyses
Barnes 2013 reported outcome data on verbal fluency - number
of words, by letter, as standardised mean changes (z-scores) at
three months. Higher values indicated improvement. Researchers
found no differences between groups (P from interaction = 0.57).
In the comparison between groups receiving sham exercise, the
mean change in z-score was 0.24 in the CCT group (95% CI -
0.11 to -0.58) and -0.05 in the educational DVD group (95% CI -
0.33 to 0.24). In the comparison between groups receiving aerobic
exercise, the mean change in z-score was 0.22 in the CCT group
(95% CI -0.15 to 0.58) and 0.08 in the educational DVD control
group (95% CI -0.21 to 0.37). We judged the quality of this
evidence to be very low (downgraded for imprecision, indirectness
of the study population, and risk of bias).
Depression
Evidence regarding depression at end of trial (Analysis 1.7) was
very low quality, downgraded because of imprecision, indirectness,
and risk of bias. Negative values favour CCT. Analysis at end of
follow-up gives SMD of -0.77 (95% CI -2.07 to 0.52; 3 studies;
101 participants). Results at individual time points are as follows:
immediate time point (12 weeks) SMD 0.22 (95% CI -0.68 to
1.13; 1 study; 19 participants) and short-term time point (12
weeks to one year) SMD -1.26 (95% CI -3.11 to 0.59; 2 studies;
82 participants).
Functional performance
Evidence regarding functional performance (Analysis 1.8) was very
low quality, downgraded because of imprecision, indirectness, and
risk of bias. Therefore we are very uncertain about this result.
Negative values favour CCT. Analysis at end of follow-up gives
SMD 0.09 (95% CI -0.51 to 0.70; 2 studies; 131 participants).
Results at individual time points are as follows: immediate time
point (12 weeks) SMD 0.33 (95% CI -0.02 to 0.67; 2 studies;
131 participants), short-term time point (12 weeks to one year)
SMD -0.29 (95% CI -1.00 to 0.41; 1 study; 31 participants), and
medium-term time point (one to two years) SMD 0.34 (95% CI
-0.06 to 0.73; 1 study; 100 participants).
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Quality of life
Evidence regarding quality of life at end of trial (12 weeks)
(Analysis 1.9) was low quality, downgraded because of imprecision
and risk of bias. Negative values favour CCT. The mean difference
(MD) was 0.40 (95% CI -1.85 to 2.65; 1 study; 19 participants).
This result indicates that there may be little or no difference in
quality of life between intervention and control groups.
Serious adverse events: mortality
Evidence regarding serious adverse events: mortality (Analysis
1.10) comes from a single study and was very low quality, down-
graded because of imprecision (double downgrading) and risk of
bias (Optale 2010). At short-term follow-up (12 weeks to one
year), the risk ratio (RR) was 0.50 (95% CI 0.05 to 5.04; 1 study;
36 participants).
Comparison 2: computerised cognition-based
interventions versus inactive control
See Summary of findings 2 for the comparison CCT versus inactive
control. This comparison included only one study (Rozzini 2007).
No data on incidence of dementia were available.
Primary outcomes
Global cognitive function
Evidence on global cognitive function at end of trial (12 months)
(Analysis 2.1; Figure 6) was very low quality, downgraded because
of imprecision, indirectness, and risk of bias. Therefore we are
very uncertain about this result. The MD was 0.36, favouring the
inactive control group (95% CI -0.30 to 1.02; 37 participants).
Figure 6. Forest plot of comparison: 2 Computerised cognition-based interventions versus inactive control,
outcome: 2.1 Global cognitive function.
Sensitivity analyses
As only a single trial contributed to the comparison, we performed
no sensitivity analysis.
Secondary outcomes
Cognitive subdomain: episodic memory
Evidence regarding episodic memory at end of trial (12 months)
(Analysis 2.2) was very low quality, downgraded because of impre-
cision, indirectness, and risk of bias. Therefore we are very uncer-
tain about this result. The MD was -2.70, favouring CCT (95%
CI -5.00 to -0.40; 37 participants).
Cognitive subdomain: executive function
Evidence regarding executive function at end of trial (12 months)
(Analysis 2.3) was very low quality, downgraded because of im-
precision, indirectness, and risk of bias. Therefore we are very un-
certain about this result. Negative values favour the CCT group.
Analysis at end of follow-up gives MD -2.70 (95% CI -6.21 to
0.81; 37 participants).
Cognitive subdomain: verbal fluency
Evidence regarding verbal fluency at end of trial (Analysis 2.4) was
very low quality, downgraded because of imprecision, indirectness,
and risk of bias. Negative values favour the CCT group. Therefore
we are very uncertain about this result. Analysis at end of follow-
up gives MD 1.90 (95% CI -4.50 to 8.30; 37 participants).
Depression
Evidence regarding depression at end of trial (Analysis 2.5) was
very low quality, downgraded because of imprecision, indirectness,
and risk of bias. Therefore we are very uncertain about this result.
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Negative values favour CCT. Analysis at end of follow-up gives
MD -1.30 (95% CI -2.61 to 0.01; 37 participants).
Functional performance
Evidence regarding functional performance (Analysis 2.6) was very
low quality, downgraded because of imprecision, indirectness, and
risk of bias. Therefore we are very uncertain about this result.
Negative values favour CCT. Analysis at end of follow-up gives
MD 0.00 (95% CI -0.48 to 0.48; 37 participants).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Computerised cognitive training compared with inactive control in people with mild cognitive impairment
Patient or population: pat ients with mild cognit ive impairment
Settings: general populat ion
Intervention: computerised cognit ive training
Comparison: inact ive control
Outcomes Difference between CCT and con-
trol (95% CI)*
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Global cognit ive funct ioning
(measured at 12 months of fol-
low-up)
MD 0.36 lower
(0.30 lower to 1.02 higher)
37 part icipants
(1 study)
⊕©©©
very lowb
It is uncertain whether CCT main-
tains global cognit ive funct ioning bet-
ter than inact ive control
Episodic memory
(measured at 12 months of fol-
low-up)
MD 2.70 lower
(5.00 lower to 0.40 lower)
37 part icipants
(1 study)
⊕©©©
very lowb
It is uncertain whether CCT improves
episodic memory compared to inac-
t ive control
Execut ive funct ion (measured at
12 months of follow-up)
MD 2.70 lower
(6.21 lower to 0.81 higher)
37 part icipants
(1 study)
⊕©©©
very lowb
It is uncertain whether CCT improves
execut ive funct ion compared to inac-
t ive control
Verbal f luency (measured at 12
months of follow-up)
MD 1.90 higher
(4.50 lower to 8.30 higher)
37 part icipants
(1 study)
⊕©©©
very lowb
It is uncertain whether CCT improves
verbal f luency compared to inact ive
control
Depression (measured at 12
months of follow-up)
MD 1.30 lower
(2.61 lower to 0.01 higher)
37 part icipants
(1 study)
⊕©©©
very lowb
It is uncertain whether CCT improves
depression compared to inact ive con-
trol
Funct ional performance (mea-
sured at 12 months of follow-up)
MD 0.00 lower
(0.48 lower to 0.48 higher)
37 part icipants
(1 study)
⊕©©©
very lowb
It is uncertain whether CCT improves
funct ional performance compared to
inact ive control
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* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CCT: computerised cognit ive training; CI: conf idence interval; MD: mean dif ference; RR: risk rat io
GRADE Working Group grades of evidence.
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
aThe direct ion of the dif ference in ef fect was standardised so that lower values favour CCT and higher values favour control
bDowngraded 3 levels for imprecision (conf idence interval included ef fects that are not clinically relevant), risk of bias, and
indirectness (cholinesterase inhibitors were included in the comparison which is not an approved medicat ion for MCI pat ients)
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D I S C U S S I O N
Summary of main results
This review examined the effects of computerised cognitive train-
ing (CCT), compared to active or inactive controls, on cognitive
function in adults with mild cognitive impairment (MCI). Eight
randomised controlled trials (RCTs) with a total of 660 partici-
pants were included. None of the studies reported on the incidence
of dementia. All evidence was low or very low quality.
Seven trials compared CCT to a variety of active control inter-
ventions. Evidence was low quality (two outcomes) or very low
quality (all other outcomes), and 95% confidence intervals (CIs)
of the effect estimates were very wide, so we are very uncertain
about all effect estimates. In our analyses, CCT appeared to im-
prove performance on the primary outcome global cognition, and
on secondary outcomes episodic memory and working memory,
compared to active controls. However, these results are based on
very low-quality evidence. We found no evidence for effects on
the cognitive subdomains of speed of processing, verbal fluency,
and executive function, nor on functional performance, quality of
life, depression, and serious adverse events, although, again, a high
level of uncertainty is associated with all these results.
One small study compared CCT versus an inactive control in-
tervention. Evidence for all outcomes was very low quality, so
we were very uncertain about all results. With this caveat, CCT
was favoured for episodic memory and executive function, but
researchers found no evidence of effects on global cognition (pri-
mary outcome) nor on any of the secondary outcomes.
Overall completeness and applicability of
evidence
The search was very broad including multiple data sources, all
article forms, and publications in any language, so it is unlikely
that relevant trials were missed. We searched for unpublished and
ongoing data, but we had to rely on published data only to com-
plete analyses. Although we did not detect publication bias, we
could not formally assess this via funnel plot evaluations because
of the small number of trials identified. Our objective was to mea-
sure treatment effects in participants with MCI at baseline, but
we also included trials that sampled participants with cognitive
deficits not meeting the MCI diagnosis ( Barnes 2013; Optale
2010). We restricted inclusion to trials with a treatment duration
of at least 12 weeks, and we excluded a significant number of tri-
als with shorter periods of intervention. Although we think that
a shorter treatment duration is less likely to result in treatment
effects, our decision implies that our results may not be applicable
to intervention programmes of shorter duration. An important
limitation of this review is that we did not identify any trial with
sufficiently long follow-up to measure effects on the incidence of
all-cause dementia.
Quality of the evidence
We restricted inclusion to RCTs that we deemed to use the most
valid approach in measuring treatment effects related to this topic.
We identified several limitations of the included studies, and we
classified none as having low risk of bias. We judged that only
one study described adequate methods of both randomisation and
allocation concealment and hence had low risk of selection bias (
Fiatarone Singh 2014). We considered none of the included studies
to have low risk of performance bias. Most studies had low risk of
detection, attrition, and reporting bias.
Upon applying GRADE criteria, we considered the quality of ev-
idence across outcomes to be very low or low, indicating that our
confidence in the effect estimate is limited and, for most outcomes,
very limited. Identified issues involving quality were due to im-
precision, inconsistency, indirectness, and risk of bias.
Potential biases in the review process
We adhered to high standards in conducting our review, with at
least two review authors independently performing trial selection,
data extraction, and quality assessment to minimise bias and tran-
scription errors. Tools used for quality assessment of trials and the
overall body of evidence are those advised by the Cochrane Collab-
oration and the GRADE Working Group. We faced an important
challenge in this and in our other Cochrane reviews evaluating
CCT: the use of multiple instruments to measure a specific cog-
nitive outcome within and across trials. Whereas others may have
preferred to consider a single preferred instrument for each cogni-
tive domain, using the mean difference to combine outcome data
across trials, we preferred to use a hierarchy to select outcome data
from a single validated instrument, employing the standardised
mean difference (SMD) to combine outcome data across trials.
Both strategies have advantages and disadvantages. For example,
with the first approach, most trials will not be considered in the
meta-analyses, as studies reported large variation in the use of in-
struments. The advantage is that all outcome data can be easily in-
terpreted on the natural scale. The advantage of using a hierarchy
is that it allows for inclusion of all trials but makes interpretation
of effect size (SMD) less intuitive. In addition, some claim that
combining data derived from multiple instruments increases be-
tween-trial heterogeneity. However, empirical evidence that sup-
ports such a claim is lacking in the field of cognitive functioning.
Yet another method is to consider all reported outcome data for a
specific cognitive domain, and to combine outcome data from all
instruments within a trial before pooling across trials. Although
this method may be valid if individual patient data are available,
we deem the risk of ecological fallacy to be high when only group
means are available. For this reason, we did not use such an ap-
proach. Some trials reported outcome data as z-score changes, and
even after we consulted several experienced statisticians, we were
unable to transform these data to allow inclusion in the meta-
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analyses. A future update of this review would benefit from clear
author descriptions regarding the type of z-score used and access
to data supplements where estimates with confidence intervals are
provided on the natural scale for each instrument.
In summary, our review is limited by the quality of included trials
and the diversity of instruments reported to measure outcomes.
Agreements and disagreements with other
studies or reviews
When we applied our rigorous quality assessment methods, we
found only very low-quality evidence for any beneficial effects of
CCT. Two recent reviews have reported some positive results. In a
recent review - Hill 2016 - review authors found an overall positive
effect on cognition across 17 MCI trials (Hedges’ g = 0.35, 95% CI
0.20 to 0.51) and small to moderate effects for global cognition,
attention, working memory, learning, memory, and psychosocial
functioning, including depressive symptoms. In a meta-analysis,
Chandler 2016 examined the effects of cognitive interventions on
more general outcome measures in MCI, including activities of
daily living, mood, and quality of life; review authors identified
only six computerised cognitive intervention studies and found
that researchers reported benefits for mood (depression, anxiety,
and apathy) among participants given the intervention compared
to those given controls.
However, overall, the literature remains mixed. In adults with MCI
or preclinical and early dementia, the number of clinical trials
remains rather limited and studies show considerable differences
between trial interventions and study methods ( Gates 2014). Al-
though multiple reviews of cognitive interventions in MCI have
reported significant immediate and longer-term benefits for cog-
nitive function, they reported on different types of interventions
such as CCT, along with cognitive stimulation and remediation,
or they included mixed populations (e.g. Chandler 2016; Coyle
2014; Kurz 2009; Reijnders 2013; Simon 2012).
Subjective cognitive decline ( SCD) is another cognitive category
that includes healthy older adults who report concerns about a
decline in cognitive function, although their performance on cog-
nitive tests is within normal limits ( Jessen 2014). Emerging ev-
idence suggests that SCD may represent a preclinical phase of
Alzheimer’s disease. Therefore it is noteworthy that a recent meta-
analyses of interventions in SCD showed benefits for cognitive
outcomes following cognitive training, even compared to active
controls ( Smart 2017).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
It is accepted that mild cognitive impairment (MCI) may represent
a transitional state between normal aging and clinical dementia in
some individuals; therefore it has been seen as an optimal period
for intervention.
We were unable to draw any firm conclusions about the efficacy
of computerised cognitive training (CCT) because of the quality
of available evidence gathered for this review. However, our re-
sults suggest that CCT may have positive effects on global cogni-
tive function, episodic memory, and working memory, when com-
pared to involvement in other cognitively stimulating activities.
Implications for research
Adults with MCI and subjective cognitive decline (SCD) may
possibly benefit from CCT in terms of improved cognitive func-
tion. This intervention therefore warrants longer-term and larger-
scale trials of improved methodological quality to examine effects
on cognition, conversion to dementia, daily functioning, mental
well-being and quality of life.
Key methodological considerations for future studies relate to se-
lection of outcome measures, duration of follow-up, and study
design. First, greater attention must be paid to generalisation of
benefits from trained tasks to other cognitive activities and daily
function. For any programme of CCT to be useful, training must
demonstrate transfer of benefits from trained to untrained tasks,
and then generalisation to global function, real-world skills, daily
function, and mental health. Selected outcomes should be sensi-
tive to subtle, and possibly non-linear change; must have high re-
liability; are available in alternative forms or are psychometrically
robust for repeated use; and are not affected by floor and ceiling
effects.
Second, assessing the maintenance of any training gains is impor-
tant. Studies with longer follow-up are needed to measure change
immediately after the intervention ends and then over time.
Third, improved reporting of study methods should be a matter
of priority because of the high proportion of unclear risks of bias.
Studies should adhere to CONSORT, improve data management
to reduce reporting of incomplete data, and develop methods to
facilitate blinding of participants and personnel. Blinding of par-
ticipants is especially important given the commercialisation of
CCT, advertisement, and widespread community exposure; an ac-
tive control comparison arm may partially address this potential
bias.
In summary, high-quality longitudinal studies with appropriately
selected outcome measures are required to determine whether
CCT can contribute to maintaining cognitive function and pre-
venting further cognitive decline and progression to clinical de-
mentia in people with MCI.
A C K N O W L E D G E M E N T S
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Barnes 2013
Methods • Design: 4-arm RCT with factorial design
• Recruitment period: 2008 to 2009
• No. of centres involved: 1
• Unit of randomisation: individuals
• No. randomised: 126
• Number of arms considered in this review: 4
• Maximum trial duration: 3 months
• Funding by non-profit organisation: this study was funded through a Career
Development Award from the National Institute on Aging (grant K01-AG024069),
the Alzheimer’s Association (grant IIRG-06-27306), the University of California
School of Medicine, and the Institutes of Health/National Center for Research
Resources/University of California, San Francisco-Clinical and Translational Science
Institute (grant KL2 RR024130)
• Funding by commercial organisation: none reported
• Publication status: full-text report
Participants • Type of MCI: participants with self-reported cognitive complaints at baseline
• Patient flow: 31 randomised, 31 described at baseline in experimental group; 32
randomised, 32 described at baseline in experimental group 2, 31 randomised, 31
described at baseline in experimental group 3; 32 randomised, 32 described at baseline
in control group
• Number of females: 18 of 31 (58%) in experimental group 1; 20 of 32 (63%) in
experimental group 2; 21 of 31 (68%) in experimental group 3; 20 of 32 (63%) in
control group 1
• Average age (SD): 74 (5.7) years in experimental group 1; 75 (6.1) years in
experimental group 2; 71 (5.5) years in experimental group 3; 74 (6.3) years in control
group 1
• Average (SD) education: 16.8 (2.3) years in experimental group 1; 16.7 (2.2)
years in experimental group 2; 15.6 (2.8) years in experimental group 3; 16.3 (2.1)
years in control group 1
• Baseline cognitive function: instrument to measure baseline cognitive function
not reported
• Selection criteria on cognition overall: mean modified Mini Mental State
examination score: 94.4; experimental group 1: global cognition (3MS) score, mean
(SD): 94.4 (3.9); experimental group 2: global cognition (3MS) score, mean (SD): 94
(5.2); experimental group 3: global cognition (3MS) score, mean (SD): 94.6 (5.6);
control group 1: global cognition (3MS) score, mean (SD): 94.8 (4.7)
• Ethnicity: experimental group 1: 0 white, 0 Indian, 0 Asian, 22 black, 0 other, 9
unclear; experimental group 2: 0 white, 0 Indian, 0 Asian, 21 black, 0 other, 11
unclear; experimental group 3: 0 white, 0 Indian, 0 Asian, 17 black, 0 other, 14
unclear; control group 1: 0 white, 0 Indian, 0 Asian, 22 black, 0 other, 10 unclear
• APOE: number of participants positive for APOE not reported
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Interventions • Type of experimental intervention 1: computerised CT and sham exercise
(stretching)
• Details of experimental intervention: intervention provided as individual
training, without supervision. Games designed to enhance the speed and accuracy of
visual and auditory processing (Posit Science). For the first 6 weeks, games focused on
visual tasks, and for the second 6 weeks, games focused on auditory tasks
• Type of experimental intervention 2: computerised CT and aerobic exercise
• Details of experimental intervention 2: computerised CT as in experimental
arm 1 but with concomitant aerobic exercise
• Type of experimental intervention 3: other
• Details of experimental intervention 3: DVDs of educational lectures on art,
history, and science and aerobic exercise
• Type of control intervention: other
• Details of control intervention: DVDs of educational lectures on art, history,
and science and sham exercise (stretching)
• Session duration: 60 minutes in all groups
• Number of treatment sessions: 36 in all groups
• Treatment frequency: 3/week in all groups
• Maximum treatment duration: 12 weeks in all groups
Outcomes • Cognitive functioning outcomes considered
◦ Global cognitive functioning measured with composite score change at 3
months, on a scale from not reported to not reported with higher values indicating
benefit
◦ Episodic memory measured with RAVLT, no. of words learned at 3 months,
on a scale from not reported to not reported with higher values indicating benefit
◦ Executive functioning measured with Trails B at 3 months, on a scale from
not reported to not reported with lower values indicating benefit
◦ Speed of processing measured with Trails A at 3 months, on a scale from not
reported to not reported with lower values indicating benefit
◦ Verbal fluency measured with no. of words by letter at 3 months, on a scale
from not reported to not reported with higher values indicating benefit
• Physical functioning outcome considered: none reported
• Quality of life outcome considered: none reported
• Safety outcome considered: none reported
• Depression outcome considered: none reported
• Available cognitive functioning outcomes not considered in this review
◦ Episodic memory measured with RAVLT No. of words recalled at 3 months,
on a scale from not reported to not reported with higher values indicating benefit
◦ Executive functioning measured with EFT Congruent reaction time at 3
months, on a scale from not reported to not reported with higher values indicating
benefit
◦ Executive functioning measured with EFT Incongruent reaction time at 3
months, on a scale from not reported to not reported with higher values indicating
benefit
◦ Speed of processing measured with DSST, No. correct at 3 months, on a
scale from not reported to not reported with higher values indicating benefit
◦ Speed of processing measured with Useful Field of View (UFOV) Processing
51Computerised cognitive training for preventing dementia in people with mild cognitive impairment (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Barnes 2013 (Continued)
speed at 3 months, on a scale from not reported to not reported with higher values
indicating benefit
◦ Verbal fluency measured with No. of words, by category at 3 months, on a
scale from not reported to not reported with higher values indicating benefit
◦ Visuospatial function (UFOV) on a scale from not reported to not reported
with higher values indicating benefit
Notes • Experimental trial arm 1 includes participants who received mental activity
intervention and group exercise control (stretching and relaxation)
• Control arm 1 includes participants who received mental activity control and
group exercise control (stretching and relaxation);
• Experimental trial arm 2 includes participants who received mental activity
intervention as experimental trial arm 1 in combination with group exercise
intervention (aerobic exercise and strength training)
• Experimental trial arm 3 includes participants who received mental activity
control (same as control arm 1) in combination with group exercise intervention
(aerobic exercise and strength training)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Judgement: random sequence adequately
generated
Quote(s): “participants were randomized
in blocks of 4. The randomization sequence
was prepared in advance by using a ran-
dom-number generator on a computer”
Allocation concealment (selection bias) Unclear risk Judgement: study authors state that alloca-
tion was concealed, although the method
of allocation concealment is not reported
Quote(s): “research staff involved with en-
rolment and outcome assessment were un-
aware of the randomization sequence and
blinded to group assignment”
Blinding of participants (performance bias) High risk Judgement: patients were not blinded to
the type of intervention
Quote(s): “study participants were un-
aware of study hypotheses and were told
that the goal of the study was to compare
the effects of different physical and mental
activity programs”
Blinding of physicians / personnel Low risk Judgement: therapists were blinded to
study treatment
Quote(s): “research staff involved with en-
rolment and outcome assessment were un-
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aware of the randomization sequence and
blinded to group assignment”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Judgement: therapists were blinded to
study treatment
Quote(s): “research staff involved with en-
rolment and outcome assessment were un-
aware of the randomization sequence and
blinded to group assignment”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement: 32 out of 32 (100%) ran-
domised to the experimental group were
analysed, and 31 out of 31 (100%) ran-
domised to the control group were ran-
domised; the statistical analyses were re-
ported to be done according to the intent-
to-treat principle; 9/32 in experimental and
3/31 in control withdrew from study but
were included in the final analysis
Quote(s): “all analyses were performed us-
ing intent-to-treat principles”
Selective reporting (reporting bias) Low risk Judgement: all outcomes mentioned in the
methods section are reported in the results
section
Other bias Low risk Judgement: no other sources of bias are
apparent
Djabelkhir 2017
Methods • Design: 2-arm RCT with parallel-group design
• Recruitment period: December 2014 to July 2015
• No. of centres involved: 1 hospital in France
• Unit of randomisation: individuals
• No. randomised: 20 (10 participants each arm)
• Number of arms considered in this review: 2
• Maximum trial duration: 3 months (12 weeks)
• Funding by non-profit organisation: none described
• Funding by commercial organisation: computerised cognitive exercises web
platform (KODRO) was provided by the company
• Publication status: full-text report
Participants • Patient flow: 53 participants were screened and 20 were randomised: 10
participants received computerised cognitive stimulation (Intervention) (CCS) and 10
received computerised cognitive engagement (control) (CCE)
• Number of females: intervention (CCS): 7 of 10 (70%); control (CCE): 6 of 10
(60%)
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• Average age (SD): intervention (CCS): 75.2 (6.4); control (CCE): 78.2 (7.0)
• Education (college degree or higher, n (%)): intervention (CCS): 4 (44.4%);
control (CCE): 6 (60%)
• Baseline cognitive function in MMSE (mean, SD): intervention (CCS): 27.7
(1.9); control (CCE): 27.4 (2.0)
• Selection criteria: inclusion criteria: community-dwelling older adults (≥ 60
years) meeting MCI criteria according to Petersen; mini Mental Status Examination
(MMSE) score > 24; reported a subjective memory complaint, preferably corroborated
by an informant; performed at/below 1.5 standard deviations (SDs) from the mean for
age and education on more than 1 neuropsychological test, with preserved or minimal
impairment in functional abilities; absence of dementia. Exclusion criteria: psychiatric
and neurological disorders (e.g. bipolar disorder, schizophrenia, stroke, Parkinson’s
disease, epilepsy); history of alcohol or other substance abuse; sensory and/or motor
deficits affecting the use of a tablet PC
• Ethnicity: not reported
• APOE: not reported
Interventions • Type of experimental intervention: computerised cognitive training (CCS),
group; treatment duration of 3 months (12 weeks); intervention provided in small
group format under trained neuropsychologist supervision
• Details of experimental intervention: intervention group attended 1 group
session per week (5 to 7 participants) for 3 months (12 sessions in total). The CCS
programme was designed to stimulate several cognitive domains with computerised
cognitive exercises and social interactions among participants. Each session was
conducted as follows: presentation of the day’s programme, recall of the last session and
discussion (15 minutes). Cognitive exercises on tablet with a short break between
exercises (60 minutes).
Feedback and group discussion about the session (15 minutes).
Computerised cognitive exercises were selected from the institution version of
KODRO (Altera-Group, Paris, France), a web-based platform that provided several
applications (e.g. appointment and event reminding, cognitive games, communication,
entertainment, videos and a library) tailored to older adults
• Type of concomitant treatment provided: not stated
• Session duration: 90 minutes in experimental group
• Number of treatment sessions: 12 in experimental group
• Treatment frequency: 1 session per week
• Maximum treatment duration in months: 3 months (12 sessions) in
experimental group
• Type of control intervention: inactive; control group (CCE) attended 1 group
session per week (5 to 7 participants) for 3 months (12 sessions in total). Each session
lasted 90 minutes and was conducted by a trained neuropsychologist blinded to
assessment
• Details of control intervention: CCE programme was designed to train
participants to use a tablet PC and to stimulate social interactions among participants.
CCE participants were involved in a casual atmosphere, while the content was
preprogrammed. A specific topic was defined for each session, and participants were
invited to explore different applications related to this. For example, for the theme
“compensating for memory problems”, participants discovered the calendar and learned
to schedule an appointment on it. During sessions, participants were invited to suggest
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a theme, and the neuropsychologist showed applications associated with the theme
• Type of concomitant treatment provided: not stated
• Session duration: 90 minutes in control group.
• Number of treatment sessions: 12 in control group
• Treatment frequency: 1/week in control group
• Maximum treatment duration in months: 3 months (12 sessions) in control
group
Outcomes • Cognitive functioning outcome considered
◦ Global cognitive function with MMSE on a scale from 0 to 30 with higher
values indicating benefit
◦ Episodic memory measured with 16-FR/CR test on a scale from not
reported to not reported with higher values indicating benefit
◦ Executive function measured in seconds with TMT-B at 12 weeks on a scale
from not reported to not reported with lower values indicating benefit
◦ Speed of processing measured with TMT-A at 12 weeks, on a scale from not
reported to not reported with lower values indicating benefit
◦ Working memory with the Backward Digit Span from the Wechsler Adult
Intelligent Scale (WAIS) 4th edition, on a scale from not reported to not reported with
higher values indicating benefit
◦ Verbal fluency measured in number of words with letter P in 2 minutes
• Physical functioning outcome considered: none reported
• Quality of life outcome considered: quality of life was assessed using the quality
of life
scale for older French people (Echelle de Qualité de Vie adpatée aux Personnes Agées)
• Safety outcome considered: none reported
• Depression outcome considered: depression symptoms measured with Goldberg
Anxiety and Depression Scales, on a scale from not reported to not reported with lower
values indicating benefit
• Other outcome data on cognitive functioning not considered in our meta-
analyses
◦ Episodic memory measured with Visuospatial memory test from the
cognitive efficiency profile, on a scale from not reported to not reported with higher
values indicating benefit
◦ Executive function measured with TMT-B error on a scale from not
reported to not reported with lower values indicating benefit
◦ Verbal fluency measured with Category Fluency, on a scale from not
reported to not reported with higher values indicating benefit
Notes KODRO provided access to the software; study authors reported no conflict of interest
in the study
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Judgement: adequate method of random
sequence generation
Quote(s): ”patients were assigned to ei-
ther a computerized CS (CCS) group
or a computerized cognitive engagement
(CCE) group with a simple computerized
randomization procedure
Allocation concealment (selection bias) Unclear risk Judgement: no description provided
Blinding of participants (performance bias) Unclear risk Judgement: study described as single-
blinded; however, it is not clear if and how
participants were blinded
Quote(s): “we designed a randomized sin-
gle-blind study conforming to Consoli-
dated Standards of Reporting Trials criteria
for pilot and feasibility studies”
Blinding of physicians / personnel High risk Judgement: therapists could not be
blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Judgement: blinded outcome assessment
Quote(s): “these were carried out by an ex-
perienced neuropsychologist blinded to the
intervention”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement: no participants were lost to
follow-up
Quote(s): “none of the participants dis-
continued the intervention. Only one par-
ticipant in the CCS group did not per-
form the M3 assessment for medical rea-
sons (surgery), resulting in 19 subjects for
the final analyses”
Selective reporting (reporting bias) Low risk Judgement: all outcomes indicated in the
methods section are reported in the results
section
Other bias Low risk Judgement: no other sources of bias are
apparent
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Methods • Design: international 4-arm RCT with factorial design
• Quote study design: “randomized, fully-factorial, double-blind, double sham
training-controlled clinical trial”
• Recruitment period: not reported
• No. of centres involved: not reported
• Unit of randomisation: individuals
• No. randomised: 100
• Number of arms considered in this review: 4
• Maximum trial duration: 18 months
• Funding by non-profit organisation: this study was funded by a National
Health and Medical Research Council (NH&MRC) of Australia Dementia Research
Grant, project grant ID No. 512672, from 2008 to 2011(https://www.nhmrc.gov.au).
Additional funding for a research assistant position was sourced from the NHMRC
Program Grant ID No. 568969, and the project was supported by the University of
Sydney and the University of New South Wales
• Funding by commercial organisation: none reported
• Publication status: full-text report
Participants • Type of MCI: MCI consistent with the Petersen 1999 criteria
• Patient flow: 24 randomised, 24 described at baseline in experimental group 1
(CT and sham physical exercise); 27 randomised, 27 described at baseline in
experimental group 2 (CT and physical exercise); 27 randomised, 27 described at
baseline in control group 1 (double sham); 22 randomised, 22 described at baseline in
control group 2 (physical exercise and sham CT)
• Number of females overall: 68 of 100 (68%)
• Average age (SD) overall: 70 (6.7) years
• Average (SD) education: not reported
• Baseline cognitive function: instrument to measure baseline cognitive function
not reported
• Selection criteria on cognition overall: Clinical Dementia Rating Algorithm (0
to 4): 0.14 (0.22); 71% rated 0, 29% rated 0.5; Mini Mental State Exam: 27 (1) (23 to
29)
• Ethnicity: not reported
• APOE: number of participants positive for APOE not reported
Interventions • Type of experimental intervention: computerised CT group, treatment duration
24 weeks; intervention provided in group format, under supervision
• Details of experimental intervention: “CT intervention involved computer-
based multimodal and multidomain exercises targeting memory, executive function,
attention, and speed of information processing. The training used the COGPACK
program”. Participants also received progressive resistance training (PRT) performed
with exercise or sham exercise (factorial design)
• Session duration: 75 minutes in experimental group
• Number of treatment sessions: 48 in experimental group
• Treatment frequency: 2/week in experimental group
• Maximum treatment duration: 24 in experimental group
• Type of control intervention: usual care, treatment duration 24 weeks;
intervention provided in group format, under supervision
• Details of control intervention: sham cognitive consisted of watching 5 short
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National Geographic videos, followed by a set of 15 questions (3/video) regarding the
presented material. Sham exercise consisted of stretching and seated callisthenics,
designed so as not to notably increase heart rate or aerobic capacity, nor improve
balance, enhance strength, or other physiological outcomes. PRT was performed with
pneumatic resistance machines (Keiser Sports Health Equipment, Ltd.,
Gloucestershire, UK), which were used for training at high intensity, with 3 sets of 8
repetitions of each of 56 exercises/session for most major muscle groups (chest press,
leg press, seated row, standing hip abduction, knee extension)
• Session duration: 60 minutes in control group
• Number of treatment sessions: 48 in control group
• Treatment frequency: 2/week in control group
• Maximum treatment duration: 24 in control group
Outcomes • Cognitive functioning outcomes considered
◦ Global cognitive functioning measured with ADAS-Cog at 6 and 18 months,
on a scale from not reported to not reported with lower values indicating benefit
◦ Episodic memory measured with Logical Memory II (delayed) at 6 and 18
months, on a scale from not reported to not reported with higher values indicating
benefit*
◦ Executive functioning measured with WAIS-III Similarities at 6 and 18
months, on a scale from not reported to not reported with higher values indicating
benefit
◦ Speed of processing measured with SDMT at 6 and 18 months, on a scale
from not reported to not reported with higher values indicating benefit
◦ Verbal fluency measured with COWAT at 6 and 18 months, on a scale from
not reported to not reported with higher values indicating benefit
• Physical functioning outcome considered
◦ Daily function measured with BAYER-ADL scale at 6 and 18 months, on a
scale from not reported to not reported with lower values indicating benefit
• Quality of life outcome considered: none reported
• Safety outcome considered: none reported
• Depression outcome considered: none reported
• Available cognitive functioning outcomes not considered in this review
◦ Global cognitive functioning measured with Global Cognition Domain at 6
and 18 months, on a scale from not reported to not reported with higher values
indicating benefit
◦ Episodic memory measured with BVRT at 6 and 18 months, on a scale from
not reported to not reported with higher values indicating benefit
◦ Episodic memory measured with Logical Memory I (immediate) at 6
months, on a scale from not reported to not reported with higher values indicating
benefit*
◦ Executive functioning measured with WAIS-III Matrices at 6 and 18
months, on a scale from not reported to not reported with higher values indicating
benefit
◦ Verbal fluency measured with Category Fluency at 6 and 18 months, on a
scale from not reported to not reported with higher values indicating benefit
*Our hierarchy did not indicate a preference for the delayed subscale over the immediate
subscale. Whenever both immediate and delayed subscales were available, the delayed
subscale was included in the meta-analyses, as it was thought to be more clinically relevant
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Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Judgement: adequate method of random
sequence generation
Quote(s): “a concealed, computer-gen-
erated sequence of randomly permuted
blocks.. in a 1:1:1:1 ratio to each of the 4
intervention arms, stratified by sex and age
(<75 and 75 years), was generated by a re-
search assistant not otherwise involved in
the study via a statistical website”
Allocation concealment (selection bias) Low risk Judgement: adequate method of conceal-
ment allocation
Quote(s): “assignments were then placed
in sealed opaque envelopes and delivered to
participants by the recruitment officer”
Blinding of participants (performance bias) Unclear risk Judgement: study described as double-
blinded; however, it is not clear if patients
were blinded
Quote(s): “all training was fully supervised
by research assistants from exercise physi-
ology or physical therapy backgrounds”
Blinding of physicians / personnel High risk Judgement: researchers supervising train-
ing were not blinded
Quote(s): “all training was fully supervised
by research assistants from exercise physi-
ology or physical therapy backgrounds”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Judgement: blinded outcome assessment
Quote(s): “blinded assessors administered
all outcome measures at baseline, 6 and 18
months”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement:
Comparison 1: 24 out of 24 (100%) ran-
domised were analysed in experimental
group 1, and 27 out of 27 (100%) ran-
domised were analysed in control group 1
Comparison 2: 27 out of 27 (100%) ran-
domised were analysed in experimental
group 2, and 22 out of 22 (100%) ran-
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domised were analysed in control group 2.
Statistical analyses were reported to be done
according to the intent-to-treat principle
Quote(s): “all patients randomised were in-
cluded in the analysis”; “n = 100 for all out-
comes”
Selective reporting (reporting bias) Low risk Judgement: all outcomes indicated in the
methods section are reported in the results
section
Other bias Low risk Judgement: no other sources of bias are
apparent
Gooding 2016
Methods • Design: 3-arm RCT with parallel-group design
• Recruitment period: not reported
• No. of centres involved: 4 (participants were recruited through the Memory
Disorders Center (MDC) at Columbia University, which includes the Alzheimer’s
Disease Research Center (ADRC), Doctors Private Offices at the Neurological
Institute, and the Memory Disorders Clinic at the New York State Psychiatric Institute
(NYSPI), as well as through the Department of Geriatric Psychiatry at the VA
Connecticut Healthcare System)
• Unit of randomisation: individuals
• No. randomised: 96 (data reported for 74 participants who completed the study
- 20 participants in the control group, 31 in the computerised cognitive training group,
and 23 in the cognitive vitality programme)
• Number of arms considered in this review: 3
• Maximum trial duration: 4 months
• Funding by non-profit organisation: funded by a grant from the Alzheimer’s
Association (IIRG-09-131861) and by a Department of Veterans Affairs RR&D
Career Development Award (RRD-B4146V)
• Funding by commercial organisation: none stated
• Publication status: full-text report
Participants • Patient flow: A total of 96 participants were recruited for this study and
completed the baseline neuropsychological evaluation. Of these, 74 participants
completed the full treatment, 7 completed partial treatment, and 15 did not complete
any portion of the assigned treatment. The overall study attrition rate was 23%.
Among those who did not complete treatment, 6 participants dropped out after the
baseline neuropsychological evaluation, 4 dropped out after completing a portion of
the 2-month follow-up evaluation, and 12 dropped out after completing the full 2-
month follow-up evaluation
Data provided only for 74 participants who completed the study:
• Number of females, n (%): 43 (58.1%)
• Average age (SD): 75.79 (8.75)
• Education (years) (mean, SD): 15.14 (2.58)
• Baseline cognitive function in mMMSE (mean, SD): 50.58 (2.72)
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• Selection criteria: study sample was recruited through the Memory Disorders
Center (MDC) at Columbia University and the VA Connecticut Healthcare System.
Inclusion criteria: diagnosis of subclinical cognitive decline established by (1) subjective
or informant memory complaints; (2) verbal memory impairment, as measured by > 0.
5 SD decline on Wechsler Memory Scale-Revised (WMS-R) Logical Memory (LM)-II,
or Buschke Selective Reminding Test (BSRT); (3) normal general cognitive function,
as determined by Mini Mental State Examination (MMSE) score > 24; and (4) normal
independent functioning as determined by physician report and > 75 percentile score
on Independent Living Scales (ILS)
• Ethnicity (%): non-Hispanic white 59.5%, African American 17.6%, Hispanic/
Latino 17.6%, Asian: 5.4%
• APOE: not reported
Interventions • Type of experimental intervention (2 arms):
◦ 1 arm computerised cognitive training (CCT) and 2 arms cognitive
vitality training (CVT): treatment phase sessions were provided in individual or group
format, twice per week, with each session lasting approximately 60 minutes. Total
exposure was the same for all treatment groups and required approximately 30 hours of
training within a 16-week period
• Details of experimental intervention:
◦ CCT: programme incorporated repeated drill-and-practice exercises
involving memory, attention, and executive functions within domain-specific training
modules that allow for adaptive training with titrated difficulty levels. Software used
was BrainFitness version 2.0.1
◦ CVT: participants in the CVT group completed the same exercises as the
CCT group using the BrainFitness programme described above, but within an
incorporated motivational therapeutic milieu based on the principles put forth by
NEAR (allowed to personalise incidental features in the training programme (i.e. can
set personal goals rather than follow clinician-set goals)), provided choice over aspects
of the training activity (i.e. can select module of choosing and set personal time
constraints), and allowed to conceptualise the training into a meaningful, real-world
situation (i.e. training programme embedded into the context of high-interest or real-
world themes, such as sport games or simulating a business transaction).This arm was
not included in the analysis
Type of concomitant treatment provided: not stated
• Session duration: 60 minutes in experimental group
• Number of treatment sessions: twice a week for 16-week period in experimental
group
• Treatment frequency: 2 sessions per week
• Maximum treatment duration in months: 16 weeks in experimental group
• Type of control intervention: active; control group, treatment phase sessions
were provided in individual or group format, twice per week, with each session lasting
approximately 60 minutes. Total exposure was the same for all treatment groups and
required approximately 30 hours of training within a 16-week period
• Details of control intervention: participants assigned to the ACG worked on
various commercially available computer games and puzzles (e.g. BrainAge, Sudoku,
crossword puzzles). Participants in this group worked on computerised games in a
similar format to individuals in the CCT group (either at the hospital or remotely from
home), and treatment dosage and intensity were identical to the CCT group (i.e. total
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of 2 hours per week)
• Type of concomitant treatment provided: not stated
• Session duration: 60 minutes in control group
• Number of treatment sessions: twice a week for 16-week period in control group
• Treatment frequency: 2 sessions per week
• Maximum treatment duration in months: 16 weeks in control group
Outcomes • Cognitive functioning outcomes considered
◦ Global cognitive function with mMMSE on a scale from not reported with
higher values indicating benefit
◦ Episodic memory with WMS-R-II subtest, on a scale from not reported to
not reported with higher values indicating benefit
◦ Working memory with the Wechsler Adult Intelligence Scale-Revised Digit
Span subtest on a scale from not reported to not reported with higher values indicating
benefit (data not reported in the study)
• Physical functioning outcome considered: none reported
• Quality of life outcome considered: none reported
• Safety outcome considered: none reported
• Depression outcome considered: depression symptoms measured with Beck
Depression Inventory 2nd Edition, on a scale from not reported to not reported with
lower values indicating benefit
• Other outcome data on cognitive functioning not considered in our meta-
analyses
◦ Episodic memory measured with BSRT verbal learning and memory, WMS-
R LM-I, WMS-R Visual reproductions I and II
Notes Funded by a grant from the Alzheimer’s Association (IIRG-09-131861) and a Depart-
ment of Veterans Affairs RR&D Career Development Award (RRD-B4146V); study
authors report no conflict of interest in the study
The third arm (CVT) consisted of CCT plus a motivational therapeutic milieu and
was not included in the analysis due to the ACG that did not receive the motivational
therapeutic milieu intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Judgement: no methods for randomisation
described
Quote(s): “this randomised clinical trial
used a test-re-test treatment controlled de-
sign with recruited patients randomly as-
signed to one of three research arms - com-
puterised cognitive training (CCT), cogni-
tive vitality training (CVT), or an active
control group (ACG)”
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Allocation concealment (selection bias) Unclear risk Judgement: no methods for allocation
concealment described
Blinding of participants (performance bias) High risk Judgement: blinding not feasible
Quote(s): none
Blinding of physicians / personnel High risk Judgement: blinding not feasible
Quote(s): none
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Judgement: no methods for blinding the
outcome assessor described
Incomplete outcome data (attrition bias)
All outcomes
High risk Judgement: high proportion of partici-
pants were lost to follow-up
Quote(s): “a total of 96 participants were
recruited for this study, and completed the
baseline neuropsychological evaluation. Of
those, 74 participants completed the full
treatment, 7 completed a partial portion
of the treatment, and 15 did not complete
any portion of the assigned treatment. The
overall study attrition rate was 23%”
Selective reporting (reporting bias) Low risk Judgement: all outcomes described in the
methods section are adequately addressed
in the results section
Other bias Low risk Judgement: no other sources of bias are
apparent
Herrera 2012
Methods • Design: 2-arm RCT with parallel-group design
• Recruitment period: not reported to not reported
• No. of centre involved: 1
• Unit of randomisation: individuals
• No. randomised: 22
• Number of arms considered in this review: 2
• Maximum trial duration: 9 months
• Funding by non-profit organisation: unclear
• Funding by commercial organisation: unclear
• Publication status: full-text report
Participants • Type of MCI: amnestic MCI multiple domains subtype (A-MCImd) consistent
with Petersen 2004 criteria
• Patient flow: 11 randomised, 11 described at baseline in experimental group; 11
randomised, 11 described at baseline in control group
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• Number of females: 5 of 11 (45%) in experimental group 1; 6 of 11 (55%) in
control group 1
• Average age (SD): 75 (2.0) years in experimental group 1; 78 (1.4) years in
control group 1
• Average (SD) education: not reported. Experimental group 1: primary: 54%;
secondary: 36%; more than secondary: 10%. Control group 1: primary: 37%;
secondary: 45%; more than secondary: 18%
• Baseline cognitive function: 3 selection criteria on cognition overall: 1)
participants meet definition criteria for A-MCImd (Petersen 2004); 2) all patients had
memory complaint; and 3) have normal general cognitive functioning as determined
by a Mini-Mental State Examination (MMSE) score ≥ 24.
• Selection criteria on cognition: experimental group 1: amnestic MCI multiple
domains subtype (A-MCImd, according to Petersen 2004). All participants had
memory complaint, usually verified by an informant. MMSE, mean (SD): 27.36 (0.
53). Control group 1: amnestic MCI multiple domains subtype (A-MCImd, according
to Petersen 2004). All participants had memory complaint, usually verified by an
informant. MMSE, mean (SD): 27.18 (0.40)
• Ethnicity: not reported
• APOE: number of participants positive for APOE not reported
Interventions • Type of experimental intervention: computerised CT group; treatment duration
12 weeks; Intervention provided in group format, under supervision
• Details of experimental intervention: training involved a memory task and an
attention task. It was programmed in Java (Release 1.4) and conducted on a Microsoft
Windows-based computer. Stimuli were pictures belonging to various categories (e.g.
animals, flowers, objects of everyday life) and common words pronounced by the
computer. Each picture was 256 × 256 pixels in size. Responses to training tasks were
given using a tactile screen, a standard keyboard (using only 2 keys), and a computer
mouse. For attention training, we used response time tasks to yes/no choice; for
memory training, we used recognition memory tasks with forced choice
• Type of concomitant treatment provided: none reported
• Session duration: 60 minutes in experimental group
• Number of treatment sessions: 24 in experimental group
• Treatment frequency: 2/week in experimental group
• Maximum treatment duration in weeks: 12 in experimental group
• Type of control intervention: other; treatment duration 12 weeks; Intervention
provided as individual training, under supervision
• Details of control intervention: cognitive activities consisting of exercises in
which participants were asked to find names of countries and corresponding capitals, to
organise a list of purchases in categories, to find similarities and differences, to choose a
newspaper article and bar all the letters “A”, to read a text and then answer questions, to
tell a story or construct a sentence from a list of words in disorder, etc.
• Session duration: 60 minutes in control group
• Number of treatment sessions: 24 in control group
• Treatment frequency: 2/week in control group
• Maximum treatment duration in weeks: 12 in control group
Outcomes • Cognitive functioning outcome considered
◦ Episodic memory measured with 16-item free and cued reminding test (16-
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FR/CR test) at 3 and 9 months, on a scale from 0 to 16 with higher values indicating
benefit
◦ Working memory measured with Digit span test, backward (type of digit
span test used not stated) at 3 and 9 months, on a scale from 0 to not reported with
higher values indicating benefit
• Physical functioning outcome considered: none reported
• Quality of life outcome considered: none reported
• Safety outcome considered: none reported
• Depression outcome considered: none reported
• Available cognitive functioning outcomes not considered in this review
◦ Episodic memory measured with MMSE-recall of 3 words at 3 months, on a
scale from 0 to not reported with higher values indicating benefit
◦ Episodic memory measured with Doors recognition subtest (doors and
people battery) set A/12 at 3 and 9 months, on a scale from 0 to not reported with
higher values indicating benefit
◦ Episodic memory measured with Doors recognition subtest (doors and
people battery) set B/12 at 3 and 9 months, on a scale from 0 to not reported with
higher values indicating benefit
◦ Episodic memory measured with 12-word-list recall test from BEM-144
memory battery (Signoret 1991) at 3 and 9 months, on a scale from 0 to 12 with
higher values indicating benefit
◦ Episodic memory measured with recall of the Rey-Osterrieth Complex
Figure at 3 and 9 months, on a scale from 0 to 36 with higher values indicating benefit
◦ Episodic memory measured with delayed matching-to-sample 48 test
(DMS48 test)-set 1 expressed as recognition score (%) at 3 and 9 months, on a scale
from 0 to not reported with higher values indicating benefit
◦ Working memory measured with Digit span test, forward, at 3 months, on a
scale from 0 to not reported with higher values indicating benefit
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Judgement: no methods for randomising
participants have been described
Quote(s): “the 22 patients were randomly
assigned into two groups (11 patients per
group): a group that performed training
(Trained group) and a group that partic-
ipated in stimulating cognitive activities
(Control group)”
Allocation concealment (selection bias) Unclear risk Judgement: no description provided
Blinding of participants (performance bias) Unclear risk Judgement: blinding not reported and in-
terventions are clearly different. Neverthe-
less, depending on the information partic-
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ipants received, blinding could have been
successful. As trial authors did not measure
this, we judged unclear risk of bias
Blinding of physicians / personnel High risk Judgement: therapists could not be
blinded
Quote(s): “three trained neuropsycholo-
gists were involved in the study: one admin-
istered and scored the pre-tests, post-tests,
and follow-up tests (this person was kept
blind to the group membership of patients)
, one supervised training, and one super-
vised cognitive activities”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Judgement: assessors were blinded to the
treatment assigned, although the method
of blinding is not described in detail
Quote(s): “three trained neuropsycholo-
gists were involved in the study: one admin-
istered and scored the pre-tests, post-tests,
and follow-up tests (this person was kept
blind to the group membership of patients)
, one supervised training, and one super-
vised cognitive activities”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement: 11 out of 11 (100%) ran-
domised were analysed in the experimen-
tal group, and 11 out of 11 (100%)
randomised were analysed in the control
group. It is not clearly reported if all ran-
domised participants were evaluated for
this test, so for statistical analyses, we used
the number randomised as the number
analysed
Selective reporting (reporting bias) Low risk Judgement: all outcomes described in the
methods section are adequately addressed
in the results section
Other bias Unclear risk Judgement: the selection process for par-
ticipants is not described in sufficient de-
tail; few baseline characteristics are de-
scribed, not allowing a judgement whether
between-group baseline imbalances oc-
curred in this small trial
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Methods • Design: 2-arm randomised controlled pilot trial with parallel-group design
• Recruitment period: not reported
• No. of centres involved: 6
• Unit of randomisation: individuals
• No. randomised: 223
• Number of arms considered in this review: 2
• Maximum trial duration: 9 months
• Funding by non-profit organisation: CADENZA, a Jockey Club Initiative for
Seniors
• Funding by commercial organisation: none described
• Publication status: full-text report
Participants • Type of MCI: not addressed
• Patient flow: 111 randomised, 111 described at baseline in experimental group;
112 randomised, 112 described at baseline in control group
• Number of females: 97 of 111 (87%) in experimental group; 93 of 112 (83%) in
control group
• Average age (SD): 75 (5.8) years in experimental group; 75 (5.8) years in control
group
• Average (SD) education: no formal education 6 (5.4%); below or at primary
level 84 (75.7%); secondary or above 21 (18.9%) in experimental group; no formal
education 14 (12.5%); below or at primary level 72 (64.3%); secondary or above 26
(23.2%) in control group
• Baseline cognitive function: measured with CMSS and CMMSE
• Selection criteria on cognition: subjective memory complaints: score ≥ 3 on
Chinese Memory Symptoms Scale (mean 4.2, SD 0.8 in experimental group; mean 4.
0, SD 0.8 in control group); no dementia: score ≥ 20 on Chinese version of Mini
Mental State Examination (mean 25.6, SD 2.5 in experimental group; mean 25.7, SD
2.5 in control group)
• Ethnicity: 111 Asian in experimental group; 112 Asian in control group
• APOE: number of participants positive for APOE not reported
Interventions • Type of experimental intervention: computerised CT, treatment duration 12
weeks; intervention provided as group training, under supervision
• Details of experimental intervention: CCT based on ACTIVE trial protocol,
with focus on attention, memory, and reasoning
• Type of concomitant treatment provided: none
• Session duration: 90 minutes in experimental group
• Number of treatment sessions: 12 in experimental group
• Treatment frequency: 1/week in experimental group
• Maximum treatment duration: 12 weeks in experimental group
• Type of control intervention: other; treatment duration 12 weeks; intervention
provided as group training, under supervision
• Details of control intervention: “series of health-related educational lectures in
small groups on prevention of mood disorder, heart diseases, diabetes, and stroke”
• Session duration: 90 minutes in control group
• Number of treatment sessions: 12 in control group
• Treatment frequency: 1/week in control group
• Maximum treatment duration: 12 weeks in control group
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Outcomes • Cognitive functioning outcome considered
◦ Global cognitive functioning measured with total score of the Chinese
version of Mattis Dementia Rating Scale (CDRS) at 12 weeks on a scale from 0 to 144,
with higher values indicating benefit
• Physical functioning outcome considered: none
• Quality of life outcome considered: none
• Depression outcome considered: none
• Safety outcome considered: none
• Available cognitive functioning outcomes not considered in this review
◦ CDRS subscale: attention at 12 weeks and 9 months on a scale from 0 to 37
with higher values indicating benefit
◦ CDRS subscale: initiation/perseveration at 12 weeks and 9 months on a
scale from 0 to 37 with higher values indicating benefit
◦ CDRS subscale: construction at 12 weeks and 9 months on a scale from 0 to
6 with higher values indicating benefit
◦ CDRS subscale: conceptualisation at 12 weeks and 9 months on a scale from
0 to 39 with higher values indicating benefit
◦ CDRS subscale: memory at 12 weeks and 9 months on a scale from 0 to 25
with higher values indicating benefit
Notes Although Kwok 2013a measured global cognitive function at 9 months of follow-up,
they did not report data for the entire study population
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Judgement: method of allocation not re-
ported
Quote(s): “single-blind randomized
placebo-controlled trial”
Allocation concealment (selection bias) Unclear risk Judgement: method of allocation conceal-
ment not reported
Quote(s): none
Blinding of participants (performance bias) High risk Judgement: blinding not feasible
Quote(s): none
Blinding of physicians / personnel High risk Judgement: blinding not feasible
Quote(s): none
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Judgement: outcome assessor explicitly re-
ported to be blind
Quote(s): “trained research assistant who
was blind to treatment assignment”
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement: 103 out of 111 (93%) ran-
domised in experimental group were anal-
ysed, and 103 out of 112 (92%) ran-
domised in control group were analysed.
Fraction with missing data below 10%
Quote(s): none; “the authors did not men-
tion analyses to be in line with intent-to-
treat principles, neither did they report on
imputation techniques”
Selective reporting (reporting bias) High risk Judgement: incomplete reporting of non-
significant outcome data for the overall
group. For example, outcome data for the
CDRS total score were not abstractable for
the overall group but were reported for sub-
groups with low, moderate, or high educa-
tional baseline values
Other bias Low risk Judgement: none detected
Optale 2010
Methods • Design: 2-arm randomised controlled pilot trial with parallel-group design
• Recruitment period: not reported
• No. of centres involved: 1
• Unit of randomisation: individuals
• No. randomised: 36
• Number of arms considered in this review: 2
• Maximum trial duration: 6 months
• Funding by non-profit organisation: Consorzio Sociale CPS gestore centro
servizi “Anni Sereni” Rest-Home, Scorzè, Venice, Italy (to Gabriele Optale). Cosimo
Urgesi was supported by the Scientific Institute (IRCCS) Eugenio Medea (Ricerca
Corrente 2009, Italian Ministry of Health)
• Funding by commercial organisation: none reported
• Publication status: full-text report
Participants • Type of MCI: not applicable; diagnosis of MCI was not required
• Patient flow: 18 randomised, 15 described at baseline in experimental group; 18
randomised, 16 described at baseline in control group
• Number of females: 10 of 15 (67%) in experimental group 1; 11 of 16 (69%) in
control group 1
• Average age (SD): 79 (10.9) years in experimental group 1; 82 (5.0) years in
control group 1
• Average (SD) education: 5.3 (2.4) years in experimental group; 6 (3.5) years in
control group
• Baseline cognitive function: measured with selection criteria on cognition
overall: presence of memory deficits as documented by a corrected total score at the
Verbal Story Recall (VSR) Test below the cut-off value (15.76)
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• Selection criteria on cognition: presence of memory deficits as documented by a
corrected total score at the Verbal Story Recall (VSR) test below the cut-off value (15.
76). Corrected MMSE score ranged from 9.7 to 29.3, with 9 participants in
experimental group presenting a score below the cut-off value (23.8) and ranging from
13.1 to 29, and with 12 participants in control group presenting a score below the cut-
off value (23.8)
• Ethnicity: not reported
• APOE: number of participants positive for APOE not reported
Interventions • Type of experimental intervention: computerised CT, individualised; treatment
duration 24 weeks; intervention provided as individual training, under supervision
• Details of experimental intervention: virtual reality memory training that
involved auditory stimulation and virtual reality experiences in path finding. VR
experiences are administered through a head-mounted display V6. The VR system runs
on a notebook PC
• Type of concomitant treatment provided: both groups participated in
recreational expressive activities (reading/discussing newspapers and magazines,
watching TV documentaries, participating in creative and painting workshops) and
assisted-mobility activities during training
• Session duration: 30 minutes in experimental group
• Number of treatment sessions: 60 in experimental group
• Treatment frequency: 3/week during first 3 months (36 sessions); 2/week in
subsequent 3 months (24 sessions) in experimental group
• Maximum treatment duration, in weeks: 24 in experimental group
• Type of control intervention: other; treatment duration 24 weeks; intervention
provided as individual training, under supervision
• Details of control intervention: “individual face-to-face training sessions using
music therapy”
• Session duration: 30 minutes in control group
• Number of treatment sessions: 60 in control group
• Treatment frequency: 3/week during first 3 months (36 sessions); 2/week in
subsequent 3 months (24 sessions) in control group
• Maximum treatment duration, in weeks: 24 in control group
Outcomes • Cognitive functioning outcomes considered
◦ Global cognitive functioning measured with Mini Mental State Examination
at 3 and 6 months, on a scale from 0 to 30, with higher values indicating benefit
◦ Episodic memory measured with Verbal Story Recall at 3 and 6 months, on
a scale from 0 to 28, with higher values indicating benefit
◦ Executive functioning measured with Dual Task Performance at 3 and 6
months, on a scale from not reported to not reported with higher values indicating
benefit
◦ Working memory measured with Digit Span (’WAIS procedure’) at 3 and 6
months, on a scale from not reported to not reported with higher values indicating
benefit
◦ Verbal fluency measured with Phonemic Verbal Fluency at 3 and 6 months,
on a scale from not reported to not reported with higher values indicating benefit
(“The PVF requires the participant to produce in 1 minute all the words he or she can
remember, starting with the letters C, P, and S”)
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• Physical functioning outcome considered
◦ Daily function measured with Activities of Daily Living - functions at 3 and
6 months, on a scale from 0 to 60, with lower values indicating benefit
• Quality of life outcome considered: none reported
• Safety outcome considered:
◦ Mortality measured at 6 months
• Depression outcome considered
◦ Depression measured with Geriatric Depression Scale at 3 and 6 months, on
a scale from 0 to 15, with lower values indicating benefit
• Available cognitive functioning outcomes not considered in this review
◦ Executive functioning measured with Cognitive Estimation Test at 3 and 6
months, on a scale from not reported to not reported with higher values indicating
benefit
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Judgement: method for generating ran-
dom sequence is not clearly reported
Quote(s): “for each replicate, half of the
participants were randomly allocated to the
EG, whereas the remaining participants
were allocated to the CG”
Allocation concealment (selection bias) Unclear risk Judgement: method of allocation conceal-
ment is not reported
Quote(s): “for each replicate, half of the
participants were randomly allocated to the
EG, whereas the remaining participants
were allocated to the CG”
Blinding of participants (performance bias) High risk Judgement: patients were not blinded
Quote(s): “a randomized controlled single-
blind procedure was used, in which the ex-
aminer administrating the clinical and neu-
ropsychological tests remained unaware of
the participants’ allocations to the EG or
CG”
Blinding of physicians / personnel High risk Judgement: therapist supervising the train-
ing was not blinded
Quote(s): “a randomized controlled single-
blind procedure was used, in which the ex-
aminer administrating the clinical and neu-
ropsychological tests remained unaware of
the participants’ allocations to the EG or
CG”
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Judgement: the outcome assessor was ex-
plicitly described to be blinded to the in-
tervention assigned
Quote(s): “the examiner administrating
the clinical and neuropsychological tests re-
mained unaware of the participants’ alloca-
tions to the EG or CG”
Incomplete outcome data (attrition bias)
All outcomes
High risk Judgement: 15 out of 18 (83%) ran-
domised in experimental group were anal-
ysed, and 16 out of 18 (89%) randomised
in control group were analysed. We judged
high risk of bias, as the percentage ran-
domised but not analysed exceeded 10%; a
complete case analyses was performed
Quote(s): “one experimental group (EG)
participant and 2 control group (CG)
participants died before completing the
booster training. Furthermore, 2 EG par-
ticipants left the rest home and went back to
their families before completing the booster
phase. Because we aimed to investigate the
effects of both the initial and the booster
training phases, the 5 participants yielding
incomplete data were not included in the
analyses”
Selective reporting (reporting bias) High risk Judgement: 1 out of 13 outcomes was not
consistently performed for unclear reasons
Quote(s): “the Trail Making Test was also
part of the evaluation protocol but could
not be administered to most participants
and was not included in the final analysis”
Other bias Unclear risk Judgement: no other potential risks of bias
detected.
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Methods • Design: 3-arm RCT with parallel-group design
• Recruitment period: not reported
• No. of centres involved: 2
• Unit of randomisation: individuals
• No. randomised: 37
• Number of arms considered in this review: 2
• Maximum trial duration: 12 months
• Funding by non-profit organisation: unclear
• Funding by commercial organisation: unclear
• Publication status: full-text report
Participants • Type of MCI: consistent with Petersen 2001 criteria
• Patient flow: 15 randomised, 15 described at baseline in experimental group; 22
randomised, 22 described at baseline in control group
• Number of females: unknown in experimental group 1; unknown in control
group 1
• Average age (SD): median age (min to max) is 63 to 78 years in experimental
group 1
• Average (SD) education: not reported
• Baseline cognitive function: instrument to measure baseline cognitive function
not reported
• Selection criteria on cognition overall: MCI Petersen criteria
• Ethnicity: not reported
• APOE: number of participants positive for APOE not reported
Interventions • Type of experimental intervention: computerised CT; intervention provided as
individual training, under supervision
• Details of experimental intervention: multi-dimensional software (TNP
software)
• Type of concomitant treatment provided: “the patients treated with ChEIs (n
¼37) received at baseline donepezil (n =26; 70%), rivastigmine (n = 6; 16%) and
galantamine (n = 5; 14%) as per the clinician’s judgment at different dosages (donepezil
5-10 mg/ daily; rivastigmine 1, 5-3 mg/b.i.d. or higher; galantamine 4-8 mg/b.i.d. or
higher). There were no statistical differences in the distributions of drugs between the
treated groups”
• Session duration: 60 minutes in experimental group
• Number of treatment sessions: 60 in experimental group
• Treatment frequency: 5/week in experimental group
• Maximum treatment duration, in weeks: 12 in experimental group
• Type of control intervention: other; treatment duration not reported;
intervention provided as individual training, without supervision
• Details of control intervention: cholinesterase inhibitors
• Session duration: not reported in control group
• Number of treatment sessions: not reported in control group
Outcomes • Cognitive functioning outcomes considered
◦ Global cognitive functioning measured with MMSE at 12 months, on a
scale from not reported to not reported with higher values indicating benefit
◦ Episodic memory measured with short story at 12 months, on a scale from
not reported to not reported with higher values indicating benefit
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◦ Executive functioning measured with Raven’s coloured matrices at 12
months, on a scale from not reported to not reported with higher values indicating
benefit
◦ Verbal fluency measured with Letter verbal fluency at 12 months, on a scale
from not reported to not reported with higher values indicating benefit
• Physical functioning outcome considered
◦ Daily function measured with BADL at 12 months, on a scale from not
reported to not reported with lower values indicating benefit
• Quality of life outcome considered
◦ Not reported
• Safety outcome considered: none reported
• Depression outcome considered
◦ Depression measured with Geriatric Depression Scale at 1 year, on a scale
from 0 to 15, with lower values indicating benefit
• Available cognitive functioning outcome not considered in this review
◦ Verbal fluency measured with Semantic verbal fluency at 12 months, on a
scale from not reported to not reported with higher values indicating benefit
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Judgement: method of random sequence
generation not reported
Quote(s): “randomisation was made by a
member of the research team”
Allocation concealment (selection bias) Unclear risk Judgement: method of allocation not re-
ported
Quote(s): “randomisation was made by a
member of the research team”
Blinding of participants (performance bias) High risk Judgement: blinding not feasible
Quote(s): none
Blinding of physicians / personnel High risk Judgement: blinding not feasible
Quote(s): none
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Judgement: blinded outcome assessors
Quote(s): “the administration of the pre-
post neuropsychological measures and the
training program were conducted by two
different experienced neuropsychologist,
blinded to the subjects’ group status”
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Judgement: 15 out of 15 (100%) ran-
domised in experimental group were anal-
ysed, and 22 out of 22 (100%) randomised
in control group were analysed. From the
Table, it seems that all included patients
were considered for inclusion in the analy-
sis, although this is not clearly reported in
the text
Selective reporting (reporting bias) Low risk Judgement: all outcomes indicated in the
methods section are reported in the results
section
Other bias Unclear risk Judgement: participants characteristics are
not described and the selection process is
not reported; it is unclear if participants
were included consecutively
16-FR/CR test: 16-item free and cued reminding test (also RI-RI-16: rappel libre / rappel indicé à 16 items)
3MS: Mini Mental State Examination.
ACG: active control group.
ADAS-Cog: Alzheimer’s Disease Assessment Scale Cognitive.
A-MCImd: amnestic MCI multiple domains subtype.
APOE: apolipoprotein E.
BADL: Brief Activities of Daily Living.
BAYER-ADL: Bayer Activities of Daily Living Scale.
BSRT: Buschke Selective Reminding Test.
BVRT: Benton Visual Retention Test.
CCE: computerised cognitive engagement.
CCS: computerised cognitive stimulation.
CG: control group.
ChEI: cholinesterase inhibitor.
CMMSE: Chinese version of Mini-Mental State Examination.
CMSS: Chinese Memory Symptoms Scale
COWAT: Controlled Oral Word Association Test.
CT: cognitive training.
CVT: cognitive vitality training.
DSST: Digit Symbol Substitution Test.
EFT: Eriksen Flanker Test
EG: experimental group.
ILS: independent living scales.
LM: logical memory.
MCI: mild cognitive impairment.
mMMSE: modified Mini Mental State Examination.
MMSE: Mini Mental State Examination.
NEAR: Neuropsychological and Educational Approach to Remediation model of treatment
PRT: progressive resistance training.
RAVLT: Rey Auditory Verbal Learning Test.
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RCT: randomised controlled test.
SD: standard deviation.
SDMT: Symbol Digit Modality Test.
TMT-B and -A: Trail Making Test-B and -A.
UFOV: useful field of view.
WAIS: Wechsler Adult Intelligence Scale.
WMS-R: Wechsler Memory Scale-Revised.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Adel 2013 Wrong study design
Alves 2014 Wrong intervention
Alves 2014a Wrong intervention
Anderson 2014 Intervention shorter than 12 weeks: 8-week intervention period (2-arm trial; n = 67; likely cognitive
healthy; mean age 63 years; extension of earlier trial)
Ann 2012 Wrong patient population
Apostolo 2014 Wrong patient population
Baglio 2011 Nature of intervention unclear
Ball 2002 Intervention shorter than 12 weeks: 5- to 6-week intervention period with 2- to 3-week booster period
at 11 and 35 months (4-arm trial ACTIVE; n = 2832; cognitively healthy; mean age 74 years)
Ball 2002a Duplicate
Ball 2006 Intervention shorter than 12 weeks. Multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Ball 2013 Intervention shorter than 12 weeks
Ballesteros 2014 Duplicate
Ballesteros 2014a Duplicate
Ballesteros 2015 Duplicate
Ballesteros 2015a Duplicate
Ballesteros 2017 Intervention shorter than 12 weeks
Bamidis 2015 Wrong study design
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Baniqued 2014 Adult population
Baniqued 2015 Younger than 30 years of age
Barban 2012 Duplicate
Barban 2016 Wrong study design
Barbosa 2015 Wrong intervention
Barcelos 2015 Wrong intervention
Barnes 2006 Intervention shorter than 12 weeks
Barnes 2009 Duplicate
Basak 2016 Intervention shorter than 12 weeks: 2 week intervention period (2-arm trial; n = 46; cognitively healthy;
mean age 69 years)
Beck 2013 Wrong intervention
Belchior 2007 Wrong outcomes
Belchior 2008 Wrong outcomes
Belleville 2006 Wrong intervention
Belleville 2014 Wrong outcomes
Berry 2010 Intervention shorter than 12 weeks: 3 to 5 weeks (2-arm trial: n = 32; cognitively healthy; mean age 72
years)
Bier 2015 Wrong study design
Binder 2016 Intervention shorter than 12 weeks
Bittner 2013 Wrong study design
Borella 2010 Intervention shorter than 12 weeks: 2 weeks (2-arm trial; n = 40; cognitively healthy; mean age 69 years)
Borella 2013 Wrong intervention
Borella 2014 Duplicate
Borella 2017 Wrong intervention
Boripuntakul 2012 Wrong intervention
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Borness 2013 Wrong patient population
Bottiroli 2009 Duplicate
Bottiroli 2009a Intervention shorter than 12 weeks: 3 training sessions (2-arm trial; n = 44; cognitively healthy; mean
age 66 years)
Bozoki 2013 Intervention shorter than 12 weeks: 6-week intervention period (2-arm trial; n = 60; cognitively healthy;
mean age 69 years)
Brehmer 2012 Intervention shorter than 12 weeks: 5-week intervention period (2-arm trial stratified by younger and
older age groups; n = 45 in old age groups, n = 55 in young age groups; cognitively healthy; mean age
64 years in old age groups, 26 in young age groups)
Brum 2013 Duplicate
Buitenweg 2017 Wrong intervention
Buiza 2008 Wrong intervention
Bureš 2016 Intervention shorter than 12 weeks
Buschert 2011 Wrong intervention
Buschert 2011a Duplicate
Buschert 2012 Wrong intervention
Buschert 2012a Duplicate
Calkins 2011 Wrong intervention
Cammarata 2011 No outcome given
Cancela 2015 Wrong patient population
Candela 2015 Wrong intervention
Cantarella 2017 Intervention shorter than 12 weeks
Cao 2016 Wrong route of administration
Carretti 2013 Wrong intervention
Casutt 2014 Wrong outcomes
Chapman 2015 Wrong intervention
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Chapman 2016 Wrong intervention
Chapman 2017 Wrong intervention
Cheng 2012 Wrong intervention
Cheng 2018 Wrong patient population
Cho 2002 Younger than 30 years of age
Cleverley 2012 Wrong intervention
Cohen-Mansfield 2014 Wrong intervention
Cohen-Mansfield 2014a Wrong intervention
Cohen-Mansfield 2015 Wrong intervention
Cohen-Mansfield 2015a Duplicate
Combourieu 2014 Wrong outcomes
Corbett 2015 Wrong patient population
Costa 2015 Wrong patient population
Danassi 2015 Duplicate
Dannhauser 2014 Wrong study design
de Almondes 2017 Intervention shorter than 12 weeks
de Macedo 2015 Wrong outcomes
De Vreese 1996 Wrong intervention
Desjardins-Crépeau 2016 Wrong patient population
Diamond 2015 Intervention shorter than 12 weeks: 7-week intervention period (2-arm trial; n = 64; cognitively healthy;
mean age 66 years)
Dittmann-Kohli 1991 Wrong intervention
Duncan 2009 Wrong intervention
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Dwolatzky 2005 Intervention shorter than 12 weeks: multiple reports for excluded trial: Wolinsky 2015 (IHAMS study)
. This citation refers to the trial registration NCT01165463
Eckroth-Bucher 2009 Wrong patient population
Edwards 2005 Intervention shorter than 12 weeks: maximum 12 sessions (2-arm SKILL trial; n = 126; participants
with initial processing speed or processing difficulty; mean age 76 years)
Edwards 2011 Intervention shorter than 12 weeks: multiple reports for Edwards 2005 (SKILL trial)
Edwards 2015 Intervention shorter than 12 weeks: planned treatment duration 10 to 12 weeks, but less than 12 weeks
provided on average
Edwards 2015a Duplicate
Efthymiou 2011 Wrong comparator.
Engvig 2014 Wrong study design
Fabre 2002 Wrong intervention
Faille 2007 Nature of intervention unclear
Fairchild 2010 Wrong intervention
Feng 2013 Wrong intervention
Feng 2015 Wrong intervention
Feng 2017 Wrong patient population
Finn 2011 Intervention shorter than 12 weeks
Finn 2015 Intervention shorter than 12 weeks: 4-week intervention period (2-arm trial; n = 41; participants with
MCI; mean age 75 years)
Finn 2015a Duplicate
Flak 2013 Study protocol
Flak 2014 Study protocol
Flak 2014a Study protocol
Flak 2016 Study protocol
Foerster 2009 No outcome given
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Forloni 2012 No outcome given
Forster 2011 Wrong intervention
Fortman 2013 Wrong comparator
Gagnon 2012 Wrong study design
Gagnon 2012a Intervention shorter than 12 weeks: 2-week intervention period (2-arm trial; n = 24; participants with
MCI; mean age 68 years)
Gaitan 2013 Wrong patient population
Gajewski 2012 Intervention shorter than 12 weeks: cognitive training over 16 weeks, of which 12 concerned comput-
erised cognitive training (4-arm trial; n = 141; cognitively healthy; mean age 71 years)
Gajewski 2017 Intervention shorter than 12 weeks
Garcia-Campuzano 2013 Nature of intervention unclear
Gates 2011 Study protocol
Gill 2016 Wrong intervention
Gillette 2009 No outcome given
Giovannini 2015 No outcome given
Giuli 2016 Wrong intervention
Giuli 2017 Wrong intervention
Golino 2017 Wrong intervention
Haesner 2015 Wrong study design
Haesner 2015a Intervention shorter than 12 weeks: 8-week intervention (2-arm trial; n = 80, 40 cognitively healthy and
40 with subjective memory complaints; mean age 70 years)
Haimov 2013 Duplicate
Haimov 2013a Duplicate
Haimov 2013b Intervention shorter than 12 weeks: 8-week intervention period (2-arm study; n = 51; likely cognitively
healthy; mean age 72 years)
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Haimov 2013c Duplicate
Haimov 2013d Intervention shorter than 12 weeks: multiple reports for Haimov 2013b
Haimov 2014 Intervention shorter than 12 weeks: multiple reports for Haimov 2013b
Haimov 2014a Intervention shorter than 12 weeks: multiple reports for Haimov 2013b
Hardy 2015 Intervention shorter than 12 weeks: 10-week intervention period (2-arm trial; n = 9919; cognitively
healthy; mean age 39 years; subgroup data by age can be analysed)
Hausmann 2012 Wrong intervention
Hayashi 2012 Wrong intervention
Hayslip B Jr 2016 Intervention shorter than 12 weeks
Heinzel 2014 Intervention shorter than 12 weeks: 4-week intervention period (2-arm trial; n = 60; 2-arm trial stratified
by younger and older age groups; n = 30 in old age groups, n = 30 in young age groups; cognitively
healthy; mean age 66 years in old age groups, 26 in young age groups)
Hudak 2013 Intervention shorter than 12 weeks: 10-week intervention period (3-arm trial; n = 53; cognitively healthy;
mean age 82 years)
Hötting 2013 Intervention shorter than 12 weeks: 6 sessions during 1 month (4-arm trial; n = 33; cognitively healthy;
mean age 49 years)
Ignjatovic 2015 Younger than 30 years of age
Irigaray 2012 Wrong intervention
Israel 1997 Nature of intervention unclear
ISRCTN70130279 Wrong intervention
Jackson 2012 Nature of intervention unclear
Jansen 2012 Wrong intervention
Jean 2010 Intervention shorter than 12 weeks: 3-week intervention period (2-arm trial; n = 22; participants with
MCI; mean age 69 years)
Jeong 2016 Wrong intervention
Jobe 2001 Intervention shorter than 12 weeks: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Jones 2013 Intervention shorter than 12 weeks: multiple reports for Ball 2002 (trial ACTIVE)
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Kampanaros 2010 Wrong intervention
Kholin 2010 Intervention shorter than 12 weeks: 30-day intervention period (2-arm trial; n = 60; participants with
MCI; age not reported; conference abstract)
Kim 2012 Wrong outcomes
Kim 2013 Intervention shorter than 12 weeks: 10-week intervention period (2-arm trial; n = 20; participants with
MCI or dementia; mean age 69 years)
Kim 2013a Wrong outcomes
Kim 2015 Nature of intervention unclear
Kim 2015a Intervention shorter than 12 weeks: 8-week intervention period (2-arm trial; n = 28; cognitively healthy;
mean age 72 years)
Kim 2015b Duplicate
Kivipelto 2014 Wrong intervention
Klusmann 2009 Duplicate
Klusmann 2010 Wrong patient population
Klusmann 2010a Duplicate
Klusmann 2011 Younger than 30 years of age
Kudelka 2014 Intervention shorter than 12 weeks: 8-week intervention period (4-arm trial; n = 96; cognitively healthy;
mean age 65 years)
Kwak 2015 Nature of intervention unclear
Kwak 2017 Nature of intervention unclear
Kwok 2013 Intervention shorter than 12 weeks: 8-week intervention period (2-arm trial; n = 194; mean MMSE
score 25.92; mean age 75 years)
Lampit 2013 Wrong study design
Lampit 2014 Wrong patient population
Lampit 2015 Wrong outcomes
Lavretsky 2016 Nature of intervention unclear
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Law 2014 Intervention shorter than 12 weeks: 10-week intervention period (2-arm trial; n = 83; participants with
MCI; mean age 74 years)
Law 2014a Duplicate
Lee 2013 Intervention shorter than 12 weeks: 6-week intervention period (2-arm trial; n = 30; mean MMSE-K
26; mean age 72 years)
Lee 2013a Intervention shorter than 12 weeks: 8-week intervention period (2-arm trial; n = 31; cognitively healthy;
mean age 65 years)
Lee 2013b Intervention shorter than 12 weeks: multiple reports for Lee 2013a
Lee 2014 Intervention shorter than 12 weeks: 8-week intervention period (2 2-arm pilots trials; n = 31 & n = 39;
likely cognitively healthy; age not reported; conference abstract that is part of multiple reports for Lee
2015)
Lee 2015 Intervention shorter than 12 weeks: 8-week intervention period (2-arm trial; n = 39; cognitively healthy;
mean age 65 years)
Legault 2011 Wrong patient population
Leon 2015 Wrong comparator
Leung 2015 Wrong patient population
Li 2010 Intervention shorter than 12 weeks: intervention period 5 weeks (2-arm trial; n = 20; cognitively healthy;
mean age 76 years)
Linde 2014 Nature of intervention unclear
Mace 2015 Intervention shorter than 12 weeks: 3-week intervention period (2-arm trial; n = 43; mild cognitive
complaints; mean age 78 years)
Mahncke 2006 Intervention shorter than 12 weeks: 8 to 10 weeks (2-arm trial; n = 182; cognitively healthy; mean age
71 years)
Man 2012 Wrong comparator
Mann 2012 Wrong study population
Margrett 2006 Wrong patient population
Mayas 2014 Intervention shorter than 12 weeks: 20 sessions provided in 10- to 12-week intervention period (n = 27;
2-arm trial; cognitively healthy; mean age 69)
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McAvinue 2013 Intervention shorter than 12 weeks: 5-week intervention period (n = 36; 2-arm trial; likely cognitively
healthy; mean age 70)
McDaniel 2014 Intervention shorter than 12 weeks: 8-week intervention period (n = 96; 4-arm trial, cognitively healthy,
mean age 65 years)
McDougall 2012 Intervention shorter than 12 weeks: 6-week intervention period (n = 41; 2-arm trial; likely cognitively
healthy; mean age 75)
Middleton 2012 Wrong intervention
Miller 2013 Intervention shorter than 12 weeks: 8-week intervention period (n = 69; 2-arm trial; cognitively healthy;
mean age 81.8)
Mohs 1998 Wrong intervention
Mombelli 2012 No outcome given
Moon 2013 Intervention shorter than 12 weeks: 10-week intervention period (n = 38; likely participants with MCI;
age not reported; conference abstract only)
Mowszowski 2014 Intervention shorter than 12 weeks: 7-week intervention period (n = 53; participants with memory
complaints, MCI or late life depression; mean age 66)
Mowszowski 2014a Duplicate
Mozolic 2010 Intervention shorter than 12 weeks: 8-week intervention period (n = 66; mean age 69; cognitively healthy
participants)
Mozolic 2011 Intervention shorter than 12 weeks: multiple reports for Mozolic 2010
Muller 2011 Nature of intervention unclear
Na 2013 Duplicate
Na 2014 Nature of intervention unclear
Naismith 2014 Duplicate
Navarro 2006 Intervention shorter than 12 weeks: 14 sessions; intervention duration not reported, but maximal follow-
up duration was 84 days (2-arm trial; n = 80; likely cognitively healthy; mean age 66 years)
NCT00544856 Nature of intervention unclear
NCT02417558 2015 Nature of intervention unclear
NCT02462135 2014 No outcome given
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NCT02480738 2012 No outcome given
NCT02512627 2015 No outcome given
NCT02747784 2016 Wrong patient population
NCT02774083 2015 Wrong comparator
NCT02785315 2016 Wrong intervention
NCT02808676 2016 Wrong intervention
Neely 2013 Nature of intervention unclear
Ng 2015 Wrong intervention
Ngandu 2015 Wrong intervention
Ngandu 2015a Wrong intervention
Nishiguchi 2015 Wrong intervention
Nouchi 2012 Intervention shorter than 12 weeks: 4-week intervention period (2-arm trial; n = 32; cognitively healthy;
mean age 69)
Nouchi 2013 Intervention shorter than 12 weeks
Nozawa 2015 Intervention shorter than 12 weeks: 8-week intervention period (3-arm trial; n = 37; cognitively healthy;
mean age 68)
O’Caoimh 2015 Intervention shorter than 12 weeks
Oei 2013 Intervention shorter than 12 weeks: 4-week intervention period (5-arm trial; n = 75; cognitively healthy;
mean age 21)
Oliveira 2013 Intervention shorter than 12 weeks: 10-week intervention period. (2-arm cohort study; n = 182; subjective
memory complaints; mean age not reported, all over 50 years of age, conference abstract only)
Otsuka 2015 Wrong study design
Park 2009 Nature of intervention unclear
Park 2014 Intervention shorter than 12 weeks: 2-week intervention period (2-arm trial; n = 40; cognitively healthy;
mean age 70)
Payne 2012 Wrong intervention
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Payne 2017 Intervention shorter than 12 weeks
Peretz 2011 Wrong patient population
R000001637 Nature of intervention unclear
Rahe 2015 Intervention shorter than 12 weeks: 6.5-week intervention period (2-arm trial; n = 30; cognitively healthy;
mean age 67 years)
Rahe 2015a Intervention shorter than 12 weeks: 7-week intervention period (3-arm trial; n = 81; cognitively healthy;
mean age 68 years)
Rebok 2013 Intervention shorter than 12 weeks: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Rebok 2014 Intervention shorter than 12 weeks: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Redick 2013 Younger than 30 years of age
Requena 2016 Wrong intervention
Rizkalla 2015 Intervention shorter than 12 weeks: 4-week intervention period (2-arm trial; n = 56; cognitively healthy;
mean age 73 years)
Rojas 2013 Wrong intervention
Rose 2015 Intervention shorter than 12 weeks: 1-month intervention period (2-arm trial; n = 59; cognitively healthy;
mean age 67 years)
Rosen 2011 Intervention shorter than 12 weeks: 2-month intervention period (2-arm pilot trial; n = 12; participants
with MCI; mean age 74)
Ryu 2013 Wrong study design
Sakka 2015 Wrong study design
Santos 2011 Wrong comparator
Schoene 2015 Duplicate
Schoene 2015a Duplicate
Schumacher 2013 Intervention shorter than 12 weeks: 10-week intervention period (3-arm trial; n = 63; cognitively healthy
participants; mean age 72; conference abstract)
Shah 2012 Wrong patient population
Shatil 2013 Wrong patient population
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Shatil 2014 Intervention shorter than 12 weeks: 8-week intervention period (2-arm trial; n = 140; cognitively healthy;
mean age 68)
Shatil 2014a Duplicate citation
Sisco 2013 Intervention shorter than 12 weeks: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Slegers 2009 Wrong intervention
Smith 2009 Intervention shorter than 12 weeks: 8-week intervention period (2-arm trial IMPACT; n = 487; cogni-
tively healthy; mean age 75 years)
Smith-Ray 2014 Intervention shorter than 12 weeks: 10-week intervention period (2-arm trial; n = 45; cognitively healthy;
mean age 72)
Smith-Ray 2015 Intervention shorter than 12 weeks: 10-week intervention period (2-arm trial; n = 51; cognitively healthy;
mean age 82)
Smith-Ray 2015a Duplicate
Solomon 2014 Wrong comparator
Song 2009 Wrong intervention
Stepankova 2014 Intervention shorter than 12 weeks: 5-week intervention period (3-arm trial; n = 68; cognitively healthy;
mean age 68 years)
Stine-Morrow 2014 Intervention shorter than 12 weeks: CCT intervention period 10 weeks (3-arm trial; n = 461; cognitively
healthy; mean age 73 years)
Strenziok 2013 Duplicate
Strenziok 2014 Intervention shorter than 12 weeks: 6-week intervention period (3-arm trial; n = 42; cognitively healthy;
mean age 69 years)
Sturz 2011 Wrong patient population
Sturz 2011a Nature of intervention unclear
Sturz 2015 Duplicate
Styliadis 2015 Intervention shorter than 12 weeks: 8-week intervention (5-arm trial; n = 70; participants with MCI;
mean age 71 years)
Styliadis 2015a Duplicate
Suo 2012 Wrong outcomes
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Szelag 2012 Intervention shorter than 12 weeks: 8-week intervention period (3-arm trial; n = 30; cognitively healthy;
mean age 69 years)
Talib 2008 Intervention shorter than 12 weeks: 4-session intervention period (2-arm trial; n = 23; cognitively healthy;
mean age 68 years)
Tappen 2014 Wrong intervention
Tennstedt 2013 Study protocol: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Tesky 2012 Wrong intervention
Tsai 2008 Wrong study design
Tsolaki 2013 Nature of intervention unclear
Tucker-Drob 2009 Wrong study design
van den Berg 2016 Intervention shorter than 12 weeks: 2-week intervention period (2-arm trial; n = 58; rehabilitation
inpatients with MMSE ≥ 21 (mean MMSE 26 with SD = 3 in experimental and 27 with SD = 3 in
control); mean age 80 years)
van der Ploeg 2016 Wrong study design
Van het Reve 2014 Wrong patient population
Vance 2007 Intervention shorter than 12 weeks: 2 to 3 months (n = 159; cognitively healthy but with speed of
processing impairment; mean age 75 years)
Vidovich 2009 Intervention shorter than 12 weeks: multiple reports for excluded trial: Vidovich 2015 (PACE trial)
Vidovich 2015 Intervention shorter than 12 weeks: 5-week intervention period (2-arm trial; n = 160; participants with
MCI; mean age 75 years; PACE trial)
Vidovich 2015a Duplicate
von Bastian 2013 Intervention shorter than 12 weeks: 4-week intervention period (2-arm trial; n = 57 in the elderly
subgroup; cognitively healthy; mean age 69 years in the elderly subgroup)
Wadley 2007 Wrong study design
Walton 2015 Intervention shorter than 12 weeks: 4-week intervention period (2-arm trial; n = 28; cognitively healthy;
mean age 64 years)
Wang 2013 Wrong intervention
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Weicker 2013 Intervention shorter than 12 weeks: 4-week intervention period (2-arm trial; n = not reported; cognitively
healthy; age 60 to 75 years; conference abstract)
Wild-Wall 2012 Wrong outcomes
Williams 2014 Intervention shorter than 12 weeks: 3-week intervention period (3-arm trial; n = 103; mild impairment
in cognition, expressed concern about cognitive changes, or mild dementia - mean MMSE = 25.3; mean
age 86 years)
Willis 1986 Intervention shorter than 12 weeks: 2-week intervention period (2-arm trial; n = 229; cognitively stable
and cognitively declined participant subgroups; mean age 73 years)
Willis 2006 Intervention shorter than 12 weeks: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Willis 2006a Duplicate
Willis 2007 Duplicate
Willis 2013 Intervention shorter than 12 weeks: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Wojtynska 2011 Intervention shorter than 12 weeks: 6-week intervention period (2-arm trial, stratified by 3 cognitive
strata; n = 34 MCI, n = 29 AD, n = 12 cognitively healthy; participants with MCI and early dementia;
mean age 69 years; conference abstract)
Wolinsky 2006 Intervention shorter than 12 weeks: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Wolinsky 2006a Intervention shorter than 12 weeks: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Wolinsky 2010 Intervention shorter than 12 weeks: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Wolinsky 2010a Intervention shorter than 12 weeks: multiple reports for excluded trial: Ball 2002 (trial ACTIVE)
Wolinsky 2013 Intervention shorter than 12 weeks: multiple reports for excluded trial: Wolinsky 2015 (IHAMS study)
Wolinsky 2015 Intervention shorter than 12 weeks: 5- to 6-week intervention period with booster at 11 months (4-
arm trial; n = 681; cognitively healthy; 50 to 64 years, n = 455; and 65 years and above, n = 226; Iowa
Healthy and Active Minds Study (IHAMS study)
Yam 2014 Wrong intervention
Yassuda 2015 Intervention shorter than 12 weeks: 8-session intervention period (2-arm trial; n = 60; participants
without depression/dementia; mean age not reported; conference abstract)
Yip 2012 Intervention shorter than 12 weeks: 5-week intervention period (3-arm trial; n = 56; participants with
acquired brain injury and subjective memory complaints; mean age 52 years)
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Yoonmi 2012 Intervention shorter than 12 weeks: 6-week intervention period (2-arm trial; n = 30; cognitively healthy;
aged 65 to 80 years)
Youn 2011 Intervention shorter than 12 weeks: 5-week intervention period (2-arm trial; n = 40; participants with
subjective memory complaints; mean age 69 years)
Zelinski 2011 Wrong study design
Zelinski 2011a Intervention shorter than 12 weeks: multiple reports for excluded trial: Smith 2009 (IMPACT)
Zhuang 2013 Wrong patient population
Zimmermann 2014 Intervention shorter than 12 weeks: 6-week intervention period (2-arm trial; n = 20; cognitively healthy;
mean age 68 years)
MMSE: Mini Mental State Examination.
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D A T A A N D A N A L Y S E S
Comparison 1. Computerised cognition-based interventions versus active control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Global cognitive function 5 Std. Mean Difference (Random, 95% CI) Subtotals only
1.1 End of trial 5 407 Std. Mean Difference (Random, 95% CI) -0.53 [-1.06, -0.01]
1.2 Immediate time point (12
weeks)
4 356 Std. Mean Difference (Random, 95% CI) -0.31 [-0.70, 0.08]
1.3 Short time point (12
weeks to 1 year)
2 82 Std. Mean Difference (Random, 95% CI) -1.23 [-1.89, -0.56]
1.4 Medium time point (1
year to 2 years)
1 100 Std. Mean Difference (Random, 95% CI) 0.16 [-0.23, 0.55]
2 Episodic memory 5 Std. Mean Difference (Random, 95% CI) Subtotals only
2.1 End of trial 5 223 Std. Mean Difference (Random, 95% CI) -0.79 [-1.54, -0.04]
2.2 Immediate time point (12
weeks)
4 172 Std. Mean Difference (Random, 95% CI) -0.99 [-1.80, -0.19]
2.3 Short time point (12
weeks to 1 year)
3 104 Std. Mean Difference (Random, 95% CI) -1.39 [-2.35, -0.44]
2.4 Medium time point (1
year to 2 years)
1 100 Std. Mean Difference (Random, 95% CI) 0.02 [-0.37, 0.41]
3 Speed of processing 2 Std. Mean Difference (Random, 95% CI) Subtotals only
3.1 End of trial 2 119 Std. Mean Difference (Random, 95% CI) 0.20 [-0.16, 0.56]
3.2 Immediate time point (12
weeks)
2 119 Std. Mean Difference (Random, 95% CI) 0.11 [-0.25, 0.47]
3.3 Medium time point (1
year to 2 years)
1 100 Std. Mean Difference (Random, 95% CI) 0.14 [-0.25, 0.53]
4 Executive function 3 Std. Mean Difference (Random, 95% CI) Subtotals only
4.1 End of trial 3 150 Std. Mean Difference (Random, 95% CI) -0.31 [-0.90, 0.28]
4.2 Immediate time point (12
weeks)
3 150 Std. Mean Difference (Random, 95% CI) -0.18 [-0.50, 0.14]
4.3 Short time point (12
weeks to 1 year)
1 31 Std. Mean Difference (Random, 95% CI) -0.81 [-1.54, -0.07]
4.4 Medium time point (1
year to 2 years)
1 100 Std. Mean Difference (Random, 95% CI) 0.08 [-0.31, 0.48]
5 Working memory 3 Std. Mean Difference (Random, 95% CI) Subtotals only
5.1 End of trial 3 72 Std. Mean Difference (Random, 95% CI) -0.88 [-1.73, -0.03]
5.2 Immediate time point (12
weeks)
3 72 Std. Mean Difference (Random, 95% CI) -0.66 [-1.26, -0.06]
5.3 Short time point (12
weeks to 1 year)
2 53 Std. Mean Difference (Random, 95% CI) -1.29 [-1.88, -0.69]
6 Verbal fluency 3 Std. Mean Difference (Random, 95% CI) Subtotals only
6.1 End of trial 3 150 Std. Mean Difference (Random, 95% CI) -0.16 [-0.76, 0.44]
6.2 Immediate time point (12
weeks)
3 150 Std. Mean Difference (Random, 95% CI) -0.02 [-0.46, 0.42]
6.3 Short time point (12
weeks to 1 year)
1 31 Std. Mean Difference (Random, 95% CI) -0.78 [-1.51, -0.04]
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6.4 Medium time point (1
year to 2 years)
1 100 Std. Mean Difference (Random, 95% CI) 0.18 [-0.22, 0.57]
7 Depression 3 Std. Mean Difference (Random, 95% CI) Subtotals only
7.1 End of trial 3 101 Std. Mean Difference (Random, 95% CI) -0.77 [-2.07, 0.52]
7.2 Immediate time point (12
weeks)
1 19 Std. Mean Difference (Random, 95% CI) 0.22 [-0.68, 1.13]
7.3 Short time point (12
weeks to 1 year)
2 82 Std. Mean Difference (Random, 95% CI) -1.26 [-3.11, 0.59]
8 Functional performance 2 Std. Mean Difference (Random, 95% CI) Subtotals only
8.1 End of trial 2 131 Std. Mean Difference (Random, 95% CI) 0.09 [-0.51, 0.70]
8.2 Immediate time point (12
weeks)
2 131 Std. Mean Difference (Random, 95% CI) 0.33 [-0.02, 0.67]
8.3 Short time point (12
weeks to 1 year)
1 31 Std. Mean Difference (Random, 95% CI) -0.29 [-1.00, 0.41]
8.4 Medium time point (1
year to 2 years)
1 100 Std. Mean Difference (Random, 95% CI) 0.34 [-0.06, 0.73]
9 Quality of life 1 Mean Difference (Random, 95% CI) Subtotals only
9.1 End of trial; 12 weeks 1 19 Mean Difference (Random, 95% CI) 0.4 [-1.85, 2.65]
10 Serious adverse events:
mortality
1 Risk Ratio (IV, Fixed, 95% CI) Subtotals only
10.1 Short time point (12
weeks to 1 year)
1 36 Risk Ratio (IV, Fixed, 95% CI) 0.5 [0.05, 5.04]
Comparison 2. Computerised cognition-based interventions versus inactive control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Global cognitive function 1 Mean Difference (Random, 95% CI) Subtotals only
1.1 End of trial, up to 1 year 1 37 Mean Difference (Random, 95% CI) 0.36 [-0.30, 1.02]
2 Episodic memory 1 Mean Difference (Random, 95% CI) Subtotals only
2.1 End of trial, up to 1 year 1 37 Mean Difference (Random, 95% CI) -2.7 [-3.00, -0.40]
3 Executive function 1 Mean Difference (Random, 95% CI) Subtotals only
3.1 End of trial, up to 1 year 1 37 Mean Difference (Random, 95% CI) -2.7 [-6.21, 0.81]
4 Verbal fluency 1 Mean Difference (Random, 95% CI) Subtotals only
4.1 End of trial, up to 1 year 1 37 Mean Difference (Random, 95% CI) 1.90 [-4.50, 8.30]
5 Depression 1 Mean Difference (Random, 95% CI) Subtotals only
5.1 End of the trial, up to 1
year
1 37 Mean Difference (Random, 95% CI) -1.3 [-2.61, 0.01]
6 Functional performance 1 Mean Difference (Random, 95% CI) Subtotals only
6.1 End of trail, up to 1 year 1 37 Mean Difference (Random, 95% CI) 0.0 [-0.48, 0.48]
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Analysis 1.1. Comparison 1 Computerised cognition-based interventions versus active control, Outcome 1
Global cognitive function.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 1 Computerised cognition-based interventions versus active control
Outcome: 1 Global cognitive function
Study or subgroup Favours CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial
Djabelkhir 2017 9 10 -0.44 (0.466) 14.9 % -0.44 [ -1.35, 0.47 ]
Fiatarone Singh 2014 51 49 0.163 (0.2) 23.5 % 0.16 [ -0.23, 0.55 ]
Gooding 2016 31 20 -0.941 (0.302) 20.1 % -0.94 [ -1.53, -0.35 ]
Kwok 2013a 103 103 -0.207 (0.14) 25.2 % -0.21 [ -0.48, 0.07 ]
Optale 2010 15 16 -1.633 (0.419) 16.3 % -1.63 [ -2.45, -0.81 ]
Subtotal (95% CI) 209 198 100.0 % -0.53 [ -1.06, -0.01 ]
Heterogeneity: Tau2 = 0.26; Chi2 = 20.51, df = 4 (P = 0.00040); I2 =80%
Test for overall effect: Z = 2.00 (P = 0.046)
2 Immediate time point (12 weeks)
Djabelkhir 2017 9 10 -0.44 (0.466) 13.2 % -0.44 [ -1.35, 0.47 ]
Fiatarone Singh 2014 51 49 0.04 (0.2) 31.8 % 0.04 [ -0.35, 0.43 ]
Kwok 2013a 103 103 -0.207 (0.14) 38.1 % -0.21 [ -0.48, 0.07 ]
Optale 2010 15 16 -1.113 (0.388) 16.9 % -1.11 [ -1.87, -0.35 ]
Subtotal (95% CI) 178 178 100.0 % -0.31 [ -0.70, 0.08 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 7.22, df = 3 (P = 0.07); I2 =58%
Test for overall effect: Z = 1.56 (P = 0.12)
3 Short time point (12 weeks to 1 year)
Gooding 2016 31 20 -0.941 (0.302) 58.8 % -0.94 [ -1.53, -0.35 ]
Optale 2010 15 16 -1.633 (0.419) 41.2 % -1.63 [ -2.45, -0.81 ]
Subtotal (95% CI) 46 36 100.0 % -1.23 [ -1.89, -0.56 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 1.80, df = 1 (P = 0.18); I2 =44%
Test for overall effect: Z = 3.60 (P = 0.00032)
4 Medium time point (1 year to 2 years)
Fiatarone Singh 2014 51 49 0.163 (0.2) 100.0 % 0.16 [ -0.23, 0.55 ]
Subtotal (95% CI) 51 49 100.0 % 0.16 [ -0.23, 0.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.42)
Test for subgroup differences: Chi2 = 13.52, df = 3 (P = 0.00), I2 =78%
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Analysis 1.2. Comparison 1 Computerised cognition-based interventions versus active control, Outcome 2
Episodic memory.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 1 Computerised cognition-based interventions versus active control
Outcome: 2 Episodic memory
Study or subgroup CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial
Optale 2010 15 16 -2.513 (0.488) 17.8 % -2.51 [ -3.47, -1.56 ]
Herrera 2012 11 11 -0.852 (0.447) 18.7 % -0.85 [ -1.73, 0.02 ]
Djabelkhir 2017 9 10 -0.556 (0.469) 18.2 % -0.56 [ -1.48, 0.36 ]
Gooding 2016 31 20 -0.396 (0.29) 21.9 % -0.40 [ -0.96, 0.17 ]
Fiatarone Singh 2014 51 49 0.018 (0.2) 23.4 % 0.02 [ -0.37, 0.41 ]
Subtotal (95% CI) 117 106 100.0 % -0.79 [ -1.54, -0.04 ]
Heterogeneity: Tau2 = 0.59; Chi2 = 24.21, df = 4 (P = 0.00007); I2 =83%
Test for overall effect: Z = 2.06 (P = 0.040)
2 Immediate time point (12 weeks)
Herrera 2012 11 11 -1.719 (0.506) 21.9 % -1.72 [ -2.71, -0.73 ]
Optale 2010 15 16 -1.658 (0.42) 24.5 % -1.66 [ -2.48, -0.83 ]
Djabelkhir 2017 9 10 -0.556 (0.469) 23.0 % -0.56 [ -1.48, 0.36 ]
Fiatarone Singh 2014 51 49 -0.271 (0.201) 30.6 % -0.27 [ -0.66, 0.12 ]
Subtotal (95% CI) 86 86 100.0 % -0.99 [ -1.80, -0.19 ]
Heterogeneity: Tau2 = 0.51; Chi2 = 13.82, df = 3 (P = 0.003); I2 =78%
Test for overall effect: Z = 2.43 (P = 0.015)
3 Short time point (12 weeks to 1 year)
Optale 2010 15 16 -2.513 (0.488) 30.4 % -2.51 [ -3.47, -1.56 ]
Gooding 2016 31 20 -0.941 (0.302) 37.5 % -0.94 [ -1.53, -0.35 ]
Herrera 2012 11 11 -0.852 (0.447) 32.0 % -0.85 [ -1.73, 0.02 ]
Subtotal (95% CI) 57 47 100.0 % -1.39 [ -2.35, -0.44 ]
Heterogeneity: Tau2 = 0.54; Chi2 = 8.54, df = 2 (P = 0.01); I2 =77%
Test for overall effect: Z = 2.86 (P = 0.0043)
4 Medium time point (1 year to 2 years)
Fiatarone Singh 2014 51 49 0.018 (0.2) 100.0 % 0.02 [ -0.37, 0.41 ]
Subtotal (95% CI) 51 49 100.0 % 0.02 [ -0.37, 0.41 ]
-1 -0.5 0 0.5 1
Favours CCT Favours active control
(Continued . . . )
95Computerised cognitive training for preventing dementia in people with mild cognitive impairment (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Heterogeneity: not applicable
Test for overall effect: Z = 0.09 (P = 0.93)
Test for subgroup differences: Chi2 = 11.65, df = 3 (P = 0.01), I2 =74%
-1 -0.5 0 0.5 1
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Analysis 1.3. Comparison 1 Computerised cognition-based interventions versus active control, Outcome 3
Speed of processing.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 1 Computerised cognition-based interventions versus active control
Outcome: 3 Speed of processing
Study or subgroup CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial
Djabelkhir 2017 9 10 0.509 (0.468) 15.4 % 0.51 [ -0.41, 1.43 ]
Fiatarone Singh 2014 51 49 0.14 (0.2) 84.6 % 0.14 [ -0.25, 0.53 ]
Subtotal (95% CI) 60 59 100.0 % 0.20 [ -0.16, 0.56 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.53, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 1.07 (P = 0.28)
2 Immediate time point (12 weeks)
Djabelkhir 2017 9 10 0.509 (0.468) 15.4 % 0.51 [ -0.41, 1.43 ]
Fiatarone Singh 2014 51 49 0.032 (0.2) 84.6 % 0.03 [ -0.36, 0.42 ]
Subtotal (95% CI) 60 59 100.0 % 0.11 [ -0.25, 0.47 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.88, df = 1 (P = 0.35); I2 =0.0%
Test for overall effect: Z = 0.57 (P = 0.57)
3 Medium time point (1 year to 2 years)
Fiatarone Singh 2014 51 49 0.14 (0.2) 100.0 % 0.14 [ -0.25, 0.53 ]
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(. . . Continued)
Study or subgroup CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 51 49 100.0 % 0.14 [ -0.25, 0.53 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.70 (P = 0.48)
Test for subgroup differences: Chi2 = 0.13, df = 2 (P = 0.94), I2 =0.0%
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Analysis 1.4. Comparison 1 Computerised cognition-based interventions versus active control, Outcome 4
Executive function.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 1 Computerised cognition-based interventions versus active control
Outcome: 4 Executive function
Study or subgroup CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial
Djabelkhir 2017 9 10 -0.419 (0.465) 24.1 % -0.42 [ -1.33, 0.49 ]
Fiatarone Singh 2014 51 49 0.084 (0.2) 45.7 % 0.08 [ -0.31, 0.48 ]
Optale 2010 15 16 -0.809 (0.375) 30.2 % -0.81 [ -1.54, -0.07 ]
Subtotal (95% CI) 75 75 100.0 % -0.31 [ -0.90, 0.28 ]
Heterogeneity: Tau2 = 0.16; Chi2 = 4.79, df = 2 (P = 0.09); I2 =58%
Test for overall effect: Z = 1.02 (P = 0.31)
2 Immediate time point (12 weeks)
Djabelkhir 2017 9 10 -0.419 (0.465) 12.5 % -0.42 [ -1.33, 0.49 ]
Fiatarone Singh 2014 51 49 -0.034 (0.2) 67.4 % -0.03 [ -0.43, 0.36 ]
Optale 2010 15 16 -0.531 (0.366) 20.1 % -0.53 [ -1.25, 0.19 ]
Subtotal (95% CI) 75 75 100.0 % -0.18 [ -0.50, 0.14 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.72, df = 2 (P = 0.42); I2 =0.0%
-2 -1 0 1 2
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(. . . Continued)
Study or subgroup CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 1.11 (P = 0.27)
3 Short time point (12 weeks to 1 year)
Optale 2010 15 16 -0.809 (0.375) 100.0 % -0.81 [ -1.54, -0.07 ]
Subtotal (95% CI) 15 16 100.0 % -0.81 [ -1.54, -0.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.16 (P = 0.031)
4 Medium time point (1 year to 2 years)
Fiatarone Singh 2014 51 49 0.084 (0.2) 100.0 % 0.08 [ -0.31, 0.48 ]
Subtotal (95% CI) 51 49 100.0 % 0.08 [ -0.31, 0.48 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.67)
Test for subgroup differences: Chi2 = 4.73, df = 3 (P = 0.19), I2 =37%
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Analysis 1.5. Comparison 1 Computerised cognition-based interventions versus active control, Outcome 5
Working memory.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 1 Computerised cognition-based interventions versus active control
Outcome: 5 Working memory
Study or subgroup CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial
Djabelkhir 2017 9 10 0 (0.459) 32.6 % 0.0 [ -0.90, 0.90 ]
Herrera 2012 11 11 -1.47 (0.486) 31.2 % -1.47 [ -2.42, -0.52 ]
Optale 2010 15 16 -1.169 (0.391) 36.2 % -1.17 [ -1.94, -0.40 ]
Subtotal (95% CI) 35 37 100.0 % -0.88 [ -1.73, -0.03 ]
Heterogeneity: Tau2 = 0.36; Chi2 = 5.69, df = 2 (P = 0.06); I2 =65%
Test for overall effect: Z = 2.04 (P = 0.041)
2 Immediate time point (12 weeks)
Djabelkhir 2017 9 10 0 (0.459) 30.4 % 0.0 [ -0.90, 0.90 ]
Herrera 2012 11 11 -1.014 (0.456) 30.7 % -1.01 [ -1.91, -0.12 ]
Optale 2010 15 16 -0.902 (0.378) 38.9 % -0.90 [ -1.64, -0.16 ]
Subtotal (95% CI) 35 37 100.0 % -0.66 [ -1.26, -0.06 ]
Heterogeneity: Tau2 = 0.10; Chi2 = 3.08, df = 2 (P = 0.21); I2 =35%
Test for overall effect: Z = 2.16 (P = 0.031)
3 Short time point (12 weeks to 1 year)
Herrera 2012 11 11 -1.47 (0.486) 39.3 % -1.47 [ -2.42, -0.52 ]
Optale 2010 15 16 -1.169 (0.391) 60.7 % -1.17 [ -1.94, -0.40 ]
Subtotal (95% CI) 26 27 100.0 % -1.29 [ -1.88, -0.69 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.23, df = 1 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 4.23 (P = 0.000024)
Test for subgroup differences: Chi2 = 2.13, df = 2 (P = 0.35), I2 =6%
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Analysis 1.6. Comparison 1 Computerised cognition-based interventions versus active control, Outcome 6
Verbal fluency.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 1 Computerised cognition-based interventions versus active control
Outcome: 6 Verbal fluency
Study or subgroup CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial
Djabelkhir 2017 9 10 -0.0137 (0.4595) 24.7 % -0.01 [ -0.91, 0.89 ]
Fiatarone Singh 2014 51 49 0.175 (0.2) 44.9 % 0.18 [ -0.22, 0.57 ]
Optale 2010 15 16 -0.777 (0.374) 30.4 % -0.78 [ -1.51, -0.04 ]
Subtotal (95% CI) 75 75 100.0 % -0.16 [ -0.76, 0.44 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 5.04, df = 2 (P = 0.08); I2 =60%
Test for overall effect: Z = 0.53 (P = 0.60)
2 Immediate time point (12 weeks)
Djabelkhir 2017 9 10 -0.0137 (0.4595) 19.0 % -0.01 [ -0.91, 0.89 ]
Fiatarone Singh 2014 51 49 0.22 (0.201) 54.0 % 0.22 [ -0.17, 0.61 ]
Optale 2010 15 16 -0.495 (0.365) 27.0 % -0.50 [ -1.21, 0.22 ]
Subtotal (95% CI) 75 75 100.0 % -0.02 [ -0.46, 0.42 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 2.96, df = 2 (P = 0.23); I2 =33%
Test for overall effect: Z = 0.08 (P = 0.94)
3 Short time point (12 weeks to 1 year)
Optale 2010 15 16 -0.777 (0.374) 100.0 % -0.78 [ -1.51, -0.04 ]
Subtotal (95% CI) 15 16 100.0 % -0.78 [ -1.51, -0.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.08 (P = 0.038)
4 Medium time point (1 year to 2 years)
Fiatarone Singh 2014 51 49 0.175 (0.2) 100.0 % 0.18 [ -0.22, 0.57 ]
Subtotal (95% CI) 51 49 100.0 % 0.18 [ -0.22, 0.57 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.87 (P = 0.38)
Test for subgroup differences: Chi2 = 5.20, df = 3 (P = 0.16), I2 =42%
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Analysis 1.7. Comparison 1 Computerised cognition-based interventions versus active control, Outcome 7
Depression.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 1 Computerised cognition-based interventions versus active control
Outcome: 7 Depression
Study or subgroup CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial
Djabelkhir 2017 9 10 0.222 (0.461) 32.2 % 0.22 [ -0.68, 1.13 ]
Gooding 2016 31 20 -0.348 (0.289) 35.6 % -0.35 [ -0.91, 0.22 ]
Optale 2010 15 16 -2.238 (0.464) 32.2 % -2.24 [ -3.15, -1.33 ]
Subtotal (95% CI) 55 46 100.0 % -0.77 [ -2.07, 0.52 ]
Heterogeneity: Tau2 = 1.15; Chi2 = 16.38, df = 2 (P = 0.00028); I2 =88%
Test for overall effect: Z = 1.17 (P = 0.24)
2 Immediate time point (12 weeks)
Djabelkhir 2017 9 10 0.222 (0.461) 100.0 % 0.22 [ -0.68, 1.13 ]
Subtotal (95% CI) 9 10 100.0 % 0.22 [ -0.68, 1.13 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
3 Short time point (12 weeks to 1 year)
Gooding 2016 31 20 -0.348 (0.289) 51.8 % -0.35 [ -0.91, 0.22 ]
Optale 2010 15 16 -2.238 (0.464) 48.2 % -2.24 [ -3.15, -1.33 ]
Subtotal (95% CI) 46 36 100.0 % -1.26 [ -3.11, 0.59 ]
Heterogeneity: Tau2 = 1.64; Chi2 = 11.95, df = 1 (P = 0.00055); I2 =92%
Test for overall effect: Z = 1.33 (P = 0.18)
Test for subgroup differences: Chi2 = 2.81, df = 2 (P = 0.25), I2 =29%
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Analysis 1.8. Comparison 1 Computerised cognition-based interventions versus active control, Outcome 8
Functional performance.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 1 Computerised cognition-based interventions versus active control
Outcome: 8 Functional performance
Study or subgroup CCT Active control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial
Fiatarone Singh 2014 51 49 0.338 (0.201) 61.3 % 0.34 [ -0.06, 0.73 ]
Optale 2010 15 16 -0.293 (0.361) 38.7 % -0.29 [ -1.00, 0.41 ]
Subtotal (95% CI) 66 65 100.0 % 0.09 [ -0.51, 0.70 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 2.33, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 0.31 (P = 0.76)
2 Immediate time point (12 weeks)
Fiatarone Singh 2014 51 49 0.338 (0.201) 76.3 % 0.34 [ -0.06, 0.73 ]
Optale 2010 15 16 0.294 (0.361) 23.7 % 0.29 [ -0.41, 1.00 ]
Subtotal (95% CI) 66 65 100.0 % 0.33 [ -0.02, 0.67 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 1.87 (P = 0.062)
3 Short time point (12 weeks to 1 year)
Optale 2010 15 16 -0.293 (0.361) 100.0 % -0.29 [ -1.00, 0.41 ]
Subtotal (95% CI) 15 16 100.0 % -0.29 [ -1.00, 0.41 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.81 (P = 0.42)
4 Medium time point (1 year to 2 years)
Fiatarone Singh 2014 51 49 0.338 (0.201) 100.0 % 0.34 [ -0.06, 0.73 ]
Subtotal (95% CI) 51 49 100.0 % 0.34 [ -0.06, 0.73 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.68 (P = 0.093)
Test for subgroup differences: Chi2 = 2.89, df = 3 (P = 0.41), I2 =0.0%
-0.5 -0.25 0 0.25 0.5
Favours CCT Favours active control
102Computerised cognitive training for preventing dementia in people with mild cognitive impairment (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.9. Comparison 1 Computerised cognition-based interventions versus active control, Outcome 9
Quality of life.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 1 Computerised cognition-based interventions versus active control
Outcome: 9 Quality of life
Study or subgroup CCT Active control Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial; 12 weeks
Djabelkhir 2017 9 10 0.4 (1.1455) 100.0 % 0.40 [ -1.85, 2.65 ]
Subtotal (95% CI) 9 10 100.0 % 0.40 [ -1.85, 2.65 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.73)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours CCT Favours active control
Analysis 1.10. Comparison 1 Computerised cognition-based interventions versus active control, Outcome
10 Serious adverse events: mortality.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 1 Computerised cognition-based interventions versus active control
Outcome: 10 Serious adverse events: mortality
Study or subgroup CCT Active control Risk Ratio Weight Risk Ratio
n/N n/N IV,Fixed,95% CI IV,Fixed,95% CI
1 Short time point (12 weeks to 1 year)
Optale 2010 1/18 2/18 100.0 % 0.50 [ 0.05, 5.04 ]
Subtotal (95% CI) 18 18 100.0 % 0.50 [ 0.05, 5.04 ]
Total events: 1 (CCT), 2 (Active control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.56)
0.01 0.1 1 10 100
Favours CCT Favours active control
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Analysis 2.1. Comparison 2 Computerised cognition-based interventions versus inactive control, Outcome
1 Global cognitive function.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 2 Computerised cognition-based interventions versus inactive control
Outcome: 1 Global cognitive function
Study or subgroup Favours CCT Inactive control Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial, up to 1 year
Rozzini 2007 15 22 0.3603 (0.3378) 100.0 % 0.36 [ -0.30, 1.02 ]
Subtotal (95% CI) 15 22 100.0 % 0.36 [ -0.30, 1.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.07 (P = 0.29)
-4 -2 0 2 4
Favours CCT Favours inactive control
Analysis 2.2. Comparison 2 Computerised cognition-based interventions versus inactive control, Outcome
2 Episodic memory.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 2 Computerised cognition-based interventions versus inactive control
Outcome: 2 Episodic memory
Study or subgroup CCT Inactive control Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial, up to 1 year
Rozzini 2007 15 22 -2.7 (1.172) 100.0 % -2.70 [ -5.00, -0.40 ]
Subtotal (95% CI) 15 22 100.0 % -2.70 [ -5.00, -0.40 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.30 (P = 0.021)
-2 -1 0 1 2
Favours CCT Favours inactive control
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Analysis 2.3. Comparison 2 Computerised cognition-based interventions versus inactive control, Outcome
3 Executive function.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 2 Computerised cognition-based interventions versus inactive control
Outcome: 3 Executive function
Study or subgroup CCT Inactive control Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial, up to 1 year
Rozzini 2007 15 22 -2.7 (1.7934) 100.0 % -2.70 [ -6.21, 0.81 ]
Subtotal (95% CI) 15 22 100.0 % -2.70 [ -6.21, 0.81 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.51 (P = 0.13)
-2 -1 0 1 2
Favours CCT Favours inactive control
Analysis 2.4. Comparison 2 Computerised cognition-based interventions versus inactive control, Outcome
4 Verbal fluency.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 2 Computerised cognition-based interventions versus inactive control
Outcome: 4 Verbal fluency
Study or subgroup CCT Inactive control Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trial, up to 1 year
Rozzini 2007 15 22 1.9 (3.2635) 100.0 % 1.90 [ -4.50, 8.30 ]
Subtotal (95% CI) 15 22 100.0 % 1.90 [ -4.50, 8.30 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
-20 -10 0 10 20
Favours CCT Favours inactive control
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Analysis 2.5. Comparison 2 Computerised cognition-based interventions versus inactive control, Outcome
5 Depression.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 2 Computerised cognition-based interventions versus inactive control
Outcome: 5 Depression
Study or subgroup CCT Inactive control Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of the trial, up to 1 year
Rozzini 2007 15 22 -1.3 (0.6664) 100.0 % -1.30 [ -2.61, 0.01 ]
Subtotal (95% CI) 15 22 100.0 % -1.30 [ -2.61, 0.01 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.95 (P = 0.051)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours CCT Favours inactive control
Analysis 2.6. Comparison 2 Computerised cognition-based interventions versus inactive control, Outcome
6 Functional performance.
Review: Computerised cognitive training for preventing dementia in people with mild cognitive impairment
Comparison: 2 Computerised cognition-based interventions versus inactive control
Outcome: 6 Functional performance
Study or subgroup Experimental Active control Mean Difference (SE)
Mean
Difference Weight
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 End of trail, up to 1 year
Rozzini 2007 15 22 0 (0.2466) 100.0 % 0.0 [ -0.48, 0.48 ]
Subtotal (95% CI) 15 22 100.0 % 0.0 [ -0.48, 0.48 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours CCT Favours inactive control
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A P P E N D I C E S
Appendix 1. Sources searched and search strategies
Source Search strategy Hits retrieved
ALOIS (www.medicine.ox.ac.uk/alois)
[Date of most recent search: 31 May 2018]
Basic search: COG
[Studies within ALOIS are coded COG if
the intervention is a cognitive-based inter-
vention]
Jan 2015: 31
Jul 2015: 4
Feb 2016: 2
Jul 2016: 0
May 2018: 1
MEDLINE In-process and other non-
indexed citations and MEDLINE 1950-
present (Ovid SP)
[Date of most recent search: 31 May 2018]
1. “cognitive stimulation”.ti,ab.
2. cognitive ADJ3 train*.ti,ab.
3. “cognitive exercis*”.ti,ab.
4. “brain train*”.ti,ab.
5. (memory adj3 train*).ti,ab.
6. “memory rehab*”.ti,ab.
7. “memory enhance*”.ti,ab.
8. “poetry-based stimulation”.ti,ab.
9. “cognitive flexibility”.ti,ab.
10. “brain exercis*”.ti,ab.
11. “cognitive rehab*”.ti,ab.
12. “mnemonic train*”.ti,ab.
13. CST.ti,ab.
14. (mental adj3 activit*).ti,ab.
15. “cognitive intervention*”.ti,ab.
16. “cognitive motor intervention*”.ti,ab.
17. “cognition based intervention*”.ti,ab.
18. “cognitive enrich*”.ti,ab.
19. Cognitive Therapy/ mt
20. or/1-19
21. *aging/
22. Aged
23. “Aged, 80 and over”
24. Middle Aged
25. Age Factors
26. *Cognition/
27. *Cognition Disorders/
28. Memory/
29. Memory Disorders/
Jan 2015: 1455
Jul 2015: 70
Feb 2016: 303
Jul 2016: 423
May 2018: 703
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(Continued)
30. Brain/
31. Mild Cognitive Impairment/
32. Executive Function/
33. (cognit* ADJ3 (func* OR declin* OR
reduc* OR impair* OR improve* OR
deficit* OR progress* 34. OR perform*)).
ti,ab
35. “mental perform*”.ti,ab.
36. memory.ti,ab.
37. “executive function*”.ti,ab.
38. MCI.ti,ab.
39. AAMI.ti,ab.
40. ACMI.ti,ab.
41. ARCD.ti,ab.
42. CIND.ti,ab.
43. (nMCI OR aMCI OR mMCI OR
MCIa).ti,ab.
44. Dementia/
45. Alzheimer Disease/
46. dement*.ti,ab.
47. alzheimer*.ti,ab.
48. “old* age*”.ti,ab.
49. elderly.ti,ab.
50. “middle age*”.ti,ab.
51. “old*adults”.ti,ab.
52. seniors.ti,ab.
53. “senior citizens”.ti,ab.
54. “community dwelling”.ti,ab.
55. pensioners.ti,ab.
56. or/21-55
57. randomized controlled trial.pt.
58. controlled clinical trial.pt.
59. randomized.ab.
60. placebo.ab.
61. drug therapy.fs.
62. randomly.ab.
63. trial.ab.
64. groups.ab.
65. or/57-64
66. exp animals/ not humans.sh.
67. 65 NOT 66
68. 67 AND 56 AND 20 [all results]
69. (“cognitive stimulation” OR “cognitive
training”).ti.
70. *Cognition
71. *Aging/
72. and/69-71
73. 72 AND 57 [‘no brainer’ results - di-
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(Continued)
rectly sent to core author team]
74. 68 NOT 73 [results minus ‘no
brainer’ results - for the crowd to screen]
Embase
1974-24 January 2018 (Ovid SP)
[Date of most recent search: 31 May 2018]
1. aging/
2. aged/
3. middle aged/
4. mild cognitive impairment/
5. elderly.ti,ab.
6. MCI.ti,ab.
7. AAMI.ti,ab.
8. ACMI.ti,ab.
9. ARCD.ti,ab.
10. CIND.ti,ab.
11. (nMCI or aMCI or mMCI or MCIa).
ti,ab.
12. “old* age*”.ti,ab.
13. elderly.ti,ab.
14. “middle age*”.ti,ab.
15. “old* aadults”.ti,ab.
16. seniors.ti,ab.
17. “senior citizens”.ti,ab.
18. “community dwelling”.ti,ab.
19. pensioners.ti,ab.
20. (“aged sample” or “aged population” or
“older sample” or “older population”).ti,ab
21. “CDR 0.5”.ti,ab.
22. (cognit* adj3 (func* or declin* or re-
duc* or impair* or improve* or deficit* or
progress* or perform* or abilit*)).ti,ab
23. or/1-22
24. *cognition/
25. memory/ or episodic memory/
26. executive function/
27. attention/
28. “mental perform*”.ti,ab.
29. memory.ti,ab.
30. dementia/
31. Alzheimer disease/
32. dement*.ti,ab.
33. alzheimer*.ti,ab.
34. or/24-33
35. randomized controlled trial/
36. controlled clinical trial/
37. (randomly adj2 allocat*).ab.
38. (randomly adj2 divide*).ab.
39. randomi?ed.ab.
40. (controlled adj7 (study or design or
Jan 2015: 1289
Jul 2015: 163
Feb 2016: 380
Jul 2016: 268
May 2018: 796
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(Continued)
trial)).ti,ab.
41. “double-blind*”.ti,ab.
42. “single blind*”.ti,ab.
43. groups.ab.
44. or/35-43
45. “cognitive stimulation”.ti,ab.
46. (cognitive adj3 train*).ti,ab.
47. “cognitive exercis*”.ti,ab.
48. “brain train*”.ti,ab.
49. (memory adj3 train*).ti,ab.
50. “memory enhance*”.ti,ab.
51. “memory rehab*”.ti,ab.
52. “brain exercis*”.ti,ab.
53. “cognitive rehab*”.ti,ab.
54. “cognitive rehab*”.ti,ab.
55. “mnemonic train*”.ti,ab.
56. CST.ti,ab.
57. (mental adj3 activit*).ti,ab.
58. “cognitive intervention*”.ti,ab.
59. “cognitive motor intervention*”.ti,ab.
60. “cognition based intervention*”.ti,ab.
61. “cognitive enrich*”.ti,ab.
62. “reality orientation”.ti,ab.
63. (memory adj2 game*).ti,ab.
64. or/45-63
65. 23 and 34 and 44 and 64
66. (“cognitive stimulation” or “cognitive
training”).ti,ab.
67. cognition/
68. (MCI or “mild cognitive impairment”
or elderly or “old* adults” or “middle age*”)
.ti
69. 66 and 67 and 68
70. 35 and 69
71. 65 not 70
PSYCINFO
1806-January week 2 2018 (Ovid SP)
[Date of most recent search: 31 May 2018]
1. exp Aging/
2. exp Cognitive Impairment/
3. “cognit* impair*”.ti,ab.
4. MCI.ti,ab.
5. AAMI.ti,ab.
6. ACMI.ti,ab.
7. ARCD.ti,ab.
8. CIND.ti,ab.
9. (nMCI or aMCI or mMCI or MCIa).ti,
ab.
10. “old* age*”.ti,ab.
11. elderly.ti,ab.
12. “middle age*”.ti,ab.
Jan 2015: 166
Jul 2015: 20
Feb 2016: 25
Jul 2016: 12
May 2018: 84
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(Continued)
13. “old* adults”.ti,ab.
14. seniors.ti,ab.
15. “senior citizens”.ti,ab.
16. “community dwelling”.ti,ab.
17. pensioners.ti,ab.
18. or/1-17
19. randomi?ed.ti.
20. (randomly adj2 allocat*).ab.
21. (randomly adj2 divide*).ab.
22. RCT.ti,ab.
23. “double-blind*”.ti,ab.
24. “single blind*”.ti,ab.
25. “randomi?ed trial”.ab.
26. “randomi?ed control* trial”.ab.
27. “random allocation”.ab.
28. “controlled clinical trial”.ti,ab.
29. (controlled adj4 (study or design or
trial)).ti,ab.
30. or/19-29
31. “cognitive stimulation”.ti,ab.
32. (cognitive adj3 train*).ti,ab.
33. “cognitive exercis*”.ti,ab.
34. “brain train*”.ti,ab.
35. (memory adj3 train*).ti,ab.
36. “memory enhance*”.ti,ab.
37. “memory rehab*”.ti,ab.
38. “brain exercis*”.ti,ab.
39. “cognitive rehab*”.ti,ab.
40. “cognitive rehab*”.ti,ab.
41. “mnemonic train*”.ti,ab.
42. CST.ti,ab.
43. (mental adj3 activit*).ti,ab.
44. “cognitive intervention*”.ti,ab.
45. “cognitive motor intervention*”.ti,ab.
46. “cognition based intervention*”.ti,ab.
47. “cognitive enrich*”.ti,ab.
48. “reality orientation”.ti,ab.
49. (memory adj2 game*).ti,ab.
50. or/31-49
51. 18 and 30 and 50
52. *Cognition/
53. (MCI or “mild cognitive impairment”
or elderly or “old* adults” or “middle age*”)
.ti
54. (“cognitive stimulation” or “cognitive
training”).ti,ab.
55. 19 or 20 or 21
56. 52 and 53 and 54 and 55
57. 51 not 56
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(Continued)
CINAHL (EBSCOhost)
[Date of most recent search: 31 May 2018]
Jan 2015: 390
Jul 2015: 13
Feb 2016: 57
Jul 2016: 12
May 2018: 181
ISI Web of Science [includes: Web
of Science (1945-present); BIOSIS Pre-
views (1926-present); MEDLINE (1950-
present); Journal Citation Reports]; BIO-
SIS Previews
[Date of most recent search: 31 May 2018]
(“mild cognitive impairment” OR elderly
OR “age* subjects” OR “old* adult*” OR
“middle age*” OR MCI) AND TOPIC:
(“randomly allocated” OR “random alloca-
tion” OR randomised OR randomized OR
RCT OR “controlled trial” OR “double
blind” OR “single blind”) AND TOPIC:
(“cognit* stim*” OR “cognit* train*” OR
puzzle OR “brain train*” OR “cognit* ex-
ercis*” OR “brain exercis*” OR “memory
exercis*” OR “brain gam*” OR “cognit*
gam*” OR “memory gam*” OR sudoku
OR crossword* OR “reality orientation”)
AND TOPIC: (cognition OR dementia
OR memory OR “executive function” OR
alzheimer*)
Timespan: All years.
Search language=Auto
Jan 2015: 333
Jul 2015: 44
Feb 2016: 108
Jul 2016: 35
May 2018: 408
LILACS (BIREME)
[Date of most recent search: 31 May 2018]
Jan 2015: 4
Jul 2015: 0
Feb 2016: 0
Jul 2016: 0
May 2018: 0
CENTRAL (via CRSO)
[Date of most recent search: 31 May 2018]
#1 MeSH descriptor: [Aged, 80 and over]
explode all trees
#2 MeSH descriptor: [Aged] explode all
trees
#3 MeSH descriptor: [Middle Aged] ex-
plode all trees
#4 MeSH descriptor: [Mild Cognitive Im-
pairment] explode all trees
#5 “cognit* impair*” or MCI
#6 elderly
#7 “old* adults”
#8 “old* age*”
#9 “old* sample”
#10 senior citizens
#11 pensioners
#12 seniors
#13 #1 or #2 or #3 or #4 or #5 or #6 or #
Jan 2015: 274
Jul 2015: 11
Feb 2016: 57
Jul 2016: 4
May 2018: 210
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(Continued)
7 or #8 or #9 or #10 or #11 or #12
#14 MeSH descriptor: [Cognition] ex-
plode all trees
#15 MeSH descriptor: [Dementia] explode
all trees
#16 cognit*
#17 memory
#18 “executive function*”
#19 processing
#20 “mental perform*”
#21 dement*
#22 alzheimer*
#23 #14 or #15 or #16 or #17 or #18 or #
19 or #20 or #21 or #22
#24 “cognitive stimulation”
#25 “cognitive training”
#26 “brain train*”
#27 “brain gam*”
#28 “memory train*” or “memory game*”
#29 puzzle*
#30 crossword*
#31 sudoku*
#32 “mental game*”
#33 “mental agil*”
#34 “cognitive exercis*”
#35 “mental exercis*”
#36 #24 or #25 or #26 or #27 or #28 or #
29 or #30 or #31 or #32 or #33 or #34 or
#35
#37 #13 and #23 and #36
Clinicaltrials.gov (www.clinicaltrials.gov)
[Date of most recent search: 31 May 2018]
Jan 2015: 17
Jul 2015: 4
Feb 2016: 2
Jul 2016: 0
May 2018: 4
ICTRP Search Portal (http:/
/apps.who.int/trialsearch) [includes Aus-
tralian New Zealand Clinical Trials Reg-
istry; ClinicalTrilas.gov; ISRCTN; Chinese
Clinical Trial Registry; Clinical Trials Reg-
istry - India; Clinical Research Informa-
tion Service - Republic of Korea; German
Clinical Trials Register; Iranian Registry
of Clinical Trials; Japan Primary Registries
Network; Pan African Clinical Trial Reg-
istry; Sri Lanka Clinical Trials Registry; The
Netherlands National Trial Register]
Jan 2015: 22
Jul 2015: 3
Feb 2016: 1
Jul 2016: 0
May 2018: 4
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[Date of most recent search: 31 May 2018]
TOTAL before de-duplication Jan 2015: 3981
Jul 2015: 332
Feb 2016: 935
Jul 2016: 754
May 2018: 2390
TOTAL: 8392
TOTAL after de-duplication TOTAL: 6233
TOTAL after first assessment by the Crowd and CDCIG Information Specialists Jan 2015: 604
Jul 2015: 60
Feb 2016: 164
Jul 2016: 73
May 2018: 190
TOTAL: 1091
Appendix 2. Definitions of design, patient, and intervention characteristics as applied in the
stratified analyses exploring between-trial variations in intervention effects
ITEM DEFINITION
Design-related characteristics*
Concealment of allocation (avoiding selection bias) Guidance from the Cochrane Handbook for Systematic Reviews of
Interventions will be used to judge bias related to sequence gener-
ation and concealment of allocation using the 2 Cochrane ’Risk
of bias’ items (Higgins 2011). From these, the statistician will de-
rive a single variable to be used in the stratified analysis: alloca-
tion concealment will be judged at low risk of bias if the inves-
tigators responsible for patient selection were unable to suspect
before allocation which treatment was next. Concealment will be
downgraded to high risk of bias if there is evidence of inadequate
sequence generation (Rutjes 2012)
Blinding of patients and personnel (avoiding performance bias) Low risk of bias will be judged:
- if a credible sham procedure was used; or if a placebo supplement
or pill was used that was reported to be identical in appearance to
the experimental intervention and the specific outcome or group
of outcomes is/are likely to be influenced by lack of blinding
- if blinding is absent or suboptimal and the specific outcome, such
as mortality, is not likely to be influenced by lack of blinding
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(Continued)
Blinding of outcome assessment (avoiding detection bias) For self-reported/partner-reported outcomes:
Low risk of bias will be judged if self-report outcomes were assessed
AND blinding of patients was considered adequate AND there
was no information to suggest that there was an investigator in-
volved during the process of outcome assessment; OR if blinding
of investigators performing the outcome assessment was reported
AND an attempt to blind patients was reported
For other outcomes:
Outcome assessment was considered to be blinded if outcome as-
sessment was reported to be blinded
Statistical analyses (avoiding attrition bias) For continuous outcomes:
Low risk of bias will be judged:
- if at least 90% of the patients randomised were analysed AND
the difference in percentage of participants not analysed was 5%
or lower across trial arms
- for trials using imputations to handle missing data: the percentage
of participants with missing data did not exceed 20% AND the
difference in percentage of participants with imputed data was 5%
or lower across trial arms AND applied imputation methods were
judged to be appropriate. Multiple imputation techniques will be
considered appropriate, simple methods such as ’last observation
carried forward’ or ’baseline carried forward’ will be considered
inappropriate
For binary outcomes of rare events:
Low risk of bias will be judged if the event rate is low (e.g. inci-
dence of dementia) AND at least 95% of the patients randomised
were analysed AND there is no evidence of differential reasons for
missing data that may alter the estimate AND the rate of missing
data does not exceed the expected event rates
For binary outcomes of non-rare events:
Low risk of bias will be judged if at least 90% of the patients
randomised were analysed AND the difference in percentage of
participants not analysed was 5% or lower across trial arms AND
there is no evidence of differential reasons for missing data that may
alter the estimate AND the rate of missing data does not exceed
the expected event rates
Trial size The cut-off to distinguish small from larger trials will be deter-
mined by a sample size calculation on the primary outcome
Publication status Full journal article vs other type or unpublished material
Follow-up duration For the cognitive outcomes, we will group studies according to
these follow-up cut-offs to describe immediate results (up to 12
weeks) and short-term (up to 1 year), medium-term (1 to 2 years)
, and longer-term results (more than 2 years)
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Treatment-related characteristics
Treatment and control
Treatment duration
Analyses will be stratified by
• control intervention (placebo vs no intervention vs usual
care, where no intervention refers to RCTs with standardised
concurrent treatments in both experimental and control arms
• training multiple domains (yes/no)
• mode of delivery
◦ training supervision (yes/no)
◦ group training (yes/no)
Analyses will be stratified into session length > 30 minutes (yes/
no), frequency > 3 sessions per week (yes/no), based upon previous
findings (Lampit 2014), and total number of sessions. The mini-
mum treatment duration of 3 months is considered short term, 3
to 12 months as medium term, and 12 months as long term. For
the outcome all-cause dementia, only outcome data at 1 year of
follow-up or longer will be considered, and therefore the grouping
will include short-term (up to 1 year), medium-term (1 to 2 years)
, and longer-term results (more than 2 years)
Participant-related characteristics
Cognition and participant-related criteria Gender, level of education (in years), ApoE-4 (yes/no), baseline
age (mid-life vs late-life vs other), and time since diagnoses
*The descriptions given in this table are provided in addition to the guidance provided by the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011). Stratified analyses are performed only for the primary outcome if about 10 RCTs contributed
to the analyses
C O N T R I B U T I O N S O F A U T H O R S
Completion of the protocol: NG, SK, AR, RV.
Screening of references: Students For Best Evidence (title/abstract screening), NG, SK, GM, RV.
Acquisition of data: NG, RV, MdN, SK, EM, AR, GV.
’Risk of bias’ assessments and GRADE-ing: NG, RV, MdN, SK, EM, AR, GM.
Statistical analysis: AR.
SoF & GRADE-ing: RV.
Overall interpretation of data: NG, RV, MdN, EM, AR, GM.
Manuscript preparation: NG, AR, RV, EM, GM.
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D I F F E R E N C E S B E T W E E N P R O T O C O L A N D R E V I E W
We planned stratified analyses to explore between-trial heterogeneity according to the features outlined in Appendix 2, and we planned
to prepare funnel plots to explore the impact of publication bias and other biases associated with small sample size. By protocol, we
indicated that about 10 trials should contribute to the analysis for it to be meaningful. As the number of trials identified was substantially
lower, we refrained from undertaking such analyses. We planned to perform one sensitivity analysis for the primary outcome, including
high-quality trials only. We aimed to define high quality by using results of the stratified analyses. As stratified analyses could not be
performed, we refrained from conducting sensitivity analyses. Although not described in our published protocol, we made the decision
to use a hierarchy to select outcome data before starting data extraction. The hierarchy itself was also established before any trial in this
and two other Cochrane reviews had started (Gates 2019a; Gates 2019b).
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